###begin article-title 0
###xml 59 67 <span type="species:ncbi:9606">Patients</span>
Factors Predicting Outcome of Total Thyroidectomy in Young Patients with Multiple Endocrine Neoplasia Type 2: A Nationwide Long-Term Follow-up Study
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 59 62 59 62 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 211 214 211 214 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 100 108 <span type="species:ncbi:9606">patients</span>
###xml 307 315 <span type="species:ncbi:9606">patients</span>
Multiple endocrine neoplasia type 2 (MEN 2) is caused by a RET mutation in chromosome 10. All MEN 2 patients develop medullary thyroid carcinoma (MTC). The age-related risk of MTC is associated with the type of RET mutation. Our aim was to identify prognostic factors associated with recurrent MTC in MEN 2 patients.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 212 215 212 215 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 40 48 <span type="species:ncbi:9606">patients</span>
###xml 244 252 <span type="species:ncbi:9606">patients</span>
In a nationwide case-control study, all patients who underwent total thyroidectomy in the Netherlands under the age of 20 years were classified into standard (1), high (2), or very high risk (3) for MTC based on RET-mutation type. Disease-free patients were compared with those with recurrent disease.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 14 22 <span type="species:ncbi:9606">patients</span>
###xml 165 173 <span type="species:ncbi:9606">patients</span>
A total of 93 patients were included in the study. Sixty-six percent had MTC on histology, the youngest being 1 year old. Codon 634 was most affected. Sixteen (18%) patients had persistent or recurrent disease, one of whom died. Significantly associated determinants of outcome in univariate analysis were higher age at surgery, no age-appropriate prophylactic surgery according to risk level, elevated preoperative calcitonin levels, affected codon, and the presence of lymph node metastases at surgery. On multivariate analysis only age of surgery was the single independent factor associated with persistent disease.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 218 226 <span type="species:ncbi:9606">patients</span>
Prophylactic thyroidectomy beyond the recommended age is associated with persistent/recurrent disease. In addition, codon 634 mutation is associated with a high risk of recurrence requiring early surgery for all these patients.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 171 174 171 174 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 566 567 566 567 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 569 570 569 570 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 859 862 859 862 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 1047 1048 1047 1048 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 1049 1050 1049 1050 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 320 328 <span type="species:ncbi:9606">patients</span>
Multiple endocrine neoplasia type 2 (MEN 2) syndrome is a rare autosomal inherited complex of endocrine tumors caused by a mutation in the REarranged during Transfection (RET) proto-oncogene located on chromosome 10. According to the mutation type, MEN 2 can be divided into MEN type 2A and 2B. Almost all MEN 2A and 2B patients develop medullary thyroid carcinoma (MTC). MTC is a neuroendocrine cancer of the calcitonin-producing parafollicular C cells. In MEN 2A, pheochromocytomas and primary hyperparathyroidism can also present in, respectively, 40 and 20-30% [1, 2]. In MEN 2B, primary hyperparathyroidism is absent; however, this disease is also characterized by the development of mucosal neuromas, intestinal ganglioneuromas, and, in some instances, a Marfanoid habitus. Familial medullary thyroid carcinoma (FMTC) is an inherited disorder caused by RET leading only to MTC. The progression from C-cell hyperplasia, the precursor lesion of MTC, to intrathyroidal MTC and eventually lymphatic and distant metastatic spread is age related [3-5].
###end p 10
###begin p 11
###xml 52 55 52 55 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 135 136 135 136 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 137 138 137 138 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 370 373 370 373 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 400 401 400 401 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 403 405 403 405 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 602 604 602 604 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 199 207 <span type="species:ncbi:9606">patients</span>
###xml 550 558 <span type="species:ncbi:9606">patients</span>
In 1993 and 1994, the relationship between germline RET proto-oncogene mutations and MEN type 2A and type 2B syndrome became apparent [6-8]. Since then, DNA analysis has become available to identify patients with hereditary MTC and to perform predictive testing in asymptomatic family members of mutation carriers. A genotype-phenotype relationship exists for different RET proto-oncogene mutations [9, 10]. The expression of MTC in terms of aggressiveness varies between the different codon mutations. Based on this genotype-phenotype relationship, patients are classified into different risk levels [11].
###end p 11
###begin p 12
###xml 325 328 325 328 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 493 494 493 494 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 496 497 496 497 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 499 501 499 501 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 503 505 503 505 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 507 509 507 509 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 18 26 <span type="species:ncbi:9606">patients</span>
###xml 425 433 <span type="species:ncbi:9606">patients</span>
In earlier years, patients underwent surgery when they presented with a clinically apparent thyroid nodule or had elevated plasma calcitonin levels. By then, many had already progressed into late-stage MTC with lymph node or distant metastases. The availability of presymptomatic DNA analysis by direct detection of germline RET proto-oncogene mutations provided a rationale to perform prophylactic surgery because in 95% of patients with MEN 2 and FMTC, C-cell hyperplasia develops into MTC [4, 9, 10, 12, 13].
###end p 12
###begin p 13
###xml 91 94 91 94 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 169 170 169 170 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 172 174 172 174 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 234 242 <span type="species:ncbi:9606">children</span>
###xml 297 305 <span type="species:ncbi:9606">patients</span>
###xml 428 436 <span type="species:ncbi:9606">patients</span>
###xml 628 636 <span type="species:ncbi:9606">patients</span>
###xml 790 798 <span type="species:ncbi:9606">patients</span>
In recent years, timing of prophylactic thyroidectomy in asymptomatic carriers of germline RET gene mutations has been customized based on the age and type of mutation [9, 10]. In an effort to further optimize the management of these children, we conducted a nationwide study, including all Dutch patients who underwent total thyroidectomy in childhood in the past 25 years. We set out to study the differences in treatment for patients operated on at the age recommended by the current guidelines and those operated on at an older age. The second purpose of this study was to assess any differences in treatment and outcome in patients treated in the era before and after genetic testing became available. Finally, our aim was to analyze prognostic risk factors for recurrent MTC in these patients.
###end p 13
###begin title 14
Materials and methods
###end title 14
###begin p 15
###xml 90 93 90 93 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 65 73 <span type="species:ncbi:9606">patients</span>
This case control study was performed in the cohort of all Dutch patients with a germline RET mutation who were operated on in one of the eight university hospitals in the Netherlands from 1980 up until 2006. Inclusion criteria were MEN 2 syndrome, 19 years or younger at the time of surgery, and had undergone a total thyroidectomy.
###end p 15
###begin p 16
###xml 77 78 77 78 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 119 120 119 120 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 157 158 157 158 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 209 210 209 210 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 252 253 252 253 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 294 295 294 295 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 340 341 340 341 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 388 389 388 389 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
The participating centers were the Free University Medical Center Amsterdam (n = 4), Leiden University Medical Center (n = 5), Academic Hospital Maastricht (n = 8), Radboud University Medical Center Nijmegen (n = 8), Academic Medical Center Amsterdam (n = 9), Erasmus Medical Center Rotterdam (n = 12), University Medical Center Groningen (n = 19), and University Medical Center Utrecht (n = 28).
###end p 16
###begin p 17
###xml 280 283 280 283 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 313 316 313 316 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 13 21 <span type="species:ncbi:9606">patients</span>
###xml 154 157 <span type="species:ncbi:28327?0.0625|species:ncbi:10274?0.05">MRV</span>
###xml 160 168 <span type="species:ncbi:9606">Patients</span>
###xml 345 353 <span type="species:ncbi:9606">patients</span>
In total, 93 patients were identified and data were collected retrospectively from hospital records in the participating centers by two authors (JMJS and MRV). Patients were divided into those who were operated on up to 1994 when predictive genetic testing became available ("pre-RET era") and those after 1994 ("RET era"). The follow-up of the patients included in this study was part of regular medical care.
###end p 17
###begin p 18
###xml 142 150 <span type="species:ncbi:9606">patients</span>
The approaches described in this article did not involve any randomization, experimental intervention, or questionnaire, and the anonymity of patients was not breached. Therefore, this article meets the conditions required under Dutch law (WGBO) for making medical and/or personal data available for statistical or other scientific research.
###end p 18
###begin title 19
Surgery
###end title 19
###begin p 20
###xml 418 421 418 421 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 558 561 558 561 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 14 22 <span type="species:ncbi:9606">patients</span>
###xml 114 122 <span type="species:ncbi:9606">patients</span>
###xml 441 449 <span type="species:ncbi:9606">patients</span>
###xml 586 594 <span type="species:ncbi:9606">patients</span>
Almost all 93 patients were operated on by a team consisting of a pediatric surgeon and an endocrine surgeon. All patients underwent total thyroidectomy. An additional prophylactic lymph node dissection of the central zone of the neck was not performed routinely. A central or lateral neck dissection was performed in case a suspicious lymph node was present during the surgery or on preoperative imaging. In the "pre-RET" era (until 1994), patients were operated on based on family history and/or elevated basal and/or stimulated calcitonin levels. In the "RET era" (after 1994), most patients were operated on based on the mutation analysis. Whenever possible, the parathyroid glands were left in situ.
###end p 20
###begin title 21
Laboratory tests
###end title 21
###begin p 22
###xml 529 531 529 531 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 534 542 <span type="species:ncbi:9606">Patients</span>
Calcitonin and pentagastrin-stimulated calcitonin levels were measured to determine the level of tumor activity. We could not retrieve all calcitonin levels, especially from the pre-RET era. However, it was often noted whether calcitonin levels were elevated. Furthermore, as each center used its own test methodology with according reference values (which differed between the participating hospitals and changed during the study period), we indicated whether these levels were elevated according to the local reference values [14]. Patients were considered cured when postoperative (pentagastrin-stimulated) calcitonin was in the lower limits of the reference values.
###end p 22
###begin title 23
Genetic testing
###end title 23
###begin p 24
###xml 49 52 49 52 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 293 296 293 296 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 375 378 375 378 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 450 453 450 453 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 525 528 525 528 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 813 815 813 815 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 1003 1004 1003 1004 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 1007 1009 1007 1009 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 1011 1018 1011 1018 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 1018 1060 1018 1060 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="25">Risk level for MTC based on codon mutation</p>
###xml 1018 1060 1018 1060 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="25">Risk level for MTC based on codon mutation</p></caption>
###xml 1060 1060 1060 1060 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1060 1070 1060 1070 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Risk level</th>
###xml 1070 1075 1070 1075 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Codon</th>
###xml 1075 1101 1075 1101 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Recommended age of surgery</th>
###xml 1060 1101 1060 1101 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left"/><th align="left">Risk level</th><th align="left">Codon</th><th align="left">Recommended age of surgery</th></tr>
###xml 1060 1101 1060 1101 <thead xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left"/><th align="left">Risk level</th><th align="left">Codon</th><th align="left">Recommended age of surgery</th></tr></thead>
###xml 1101 1102 1101 1102 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 1102 1115 1102 1115 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Standard risk</td>
###xml 1115 1142 1115 1142 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">768, 790, 791, 804, and 891</td>
###xml 1142 1152 1142 1152 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5&#8211;10&#160;years</td>
###xml 1101 1152 1101 1152 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">1</td><td align="left">Standard risk</td><td align="left">768, 790, 791, 804, and 891</td><td align="left">5&#8211;10&#160;years</td></tr>
###xml 1152 1153 1152 1153 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2</td>
###xml 1153 1162 1153 1162 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">High risk</td>
###xml 1162 1194 1162 1194 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">630, 634, 609, 611, 618, and 620</td>
###xml 1194 1202 1194 1202 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&lt;5&#160;years</td>
###xml 1152 1202 1152 1202 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">2</td><td align="left">High risk</td><td align="left">630, 634, 609, 611, 618, and 620</td><td align="left">&lt;5&#160;years</td></tr>
###xml 1202 1203 1202 1203 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3</td>
###xml 1203 1217 1203 1217 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Very high risk</td>
###xml 1217 1234 1217 1234 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">918, 883, and 922</td>
###xml 1234 1243 1234 1243 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&lt;6&#160;months</td>
###xml 1202 1243 1202 1243 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">3</td><td align="left">Very high risk</td><td align="left">918, 883, and 922</td><td align="left">&lt;6&#160;months</td></tr>
###xml 1101 1243 1101 1243 <tbody xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">1</td><td align="left">Standard risk</td><td align="left">768, 790, 791, 804, and 891</td><td align="left">5&#8211;10&#160;years</td></tr><tr><td align="left">2</td><td align="left">High risk</td><td align="left">630, 634, 609, 611, 618, and 620</td><td align="left">&lt;5&#160;years</td></tr><tr><td align="left">3</td><td align="left">Very high risk</td><td align="left">918, 883, and 922</td><td align="left">&lt;6&#160;months</td></tr></tbody>
###xml 1060 1243 1060 1243 <table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Risk level</th><th align="left">Codon</th><th align="left">Recommended age of surgery</th></tr></thead><tbody><tr><td align="left">1</td><td align="left">Standard risk</td><td align="left">768, 790, 791, 804, and 891</td><td align="left">5&#8211;10&#160;years</td></tr><tr><td align="left">2</td><td align="left">High risk</td><td align="left">630, 634, 609, 611, 618, and 620</td><td align="left">&lt;5&#160;years</td></tr><tr><td align="left">3</td><td align="left">Very high risk</td><td align="left">918, 883, and 922</td><td align="left">&lt;6&#160;months</td></tr></tbody></table>
###xml 1372 1374 1372 1374 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 1376 1378 1376 1378 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 1243 1379 1243 1379 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="26">Risk level of MTC based on the 1999 consensus statement from the Seventh International Workshop on Multiple Endocrine Neoplasia [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]</p>
###xml 1243 1379 1243 1379 <table-wrap-foot xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="26">Risk level of MTC based on the 1999 consensus statement from the Seventh International Workshop on Multiple Endocrine Neoplasia [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]</p></table-wrap-foot>
###xml 1011 1379 1011 1379 <table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="25">Risk level for MTC based on codon mutation</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Risk level</th><th align="left">Codon</th><th align="left">Recommended age of surgery</th></tr></thead><tbody><tr><td align="left">1</td><td align="left">Standard risk</td><td align="left">768, 790, 791, 804, and 891</td><td align="left">5&#8211;10&#160;years</td></tr><tr><td align="left">2</td><td align="left">High risk</td><td align="left">630, 634, 609, 611, 618, and 620</td><td align="left">&lt;5&#160;years</td></tr><tr><td align="left">3</td><td align="left">Very high risk</td><td align="left">918, 883, and 922</td><td align="left">&lt;6&#160;months</td></tr></tbody></table><table-wrap-foot><p textid="26">Risk level of MTC based on the 1999 consensus statement from the Seventh International Workshop on Multiple Endocrine Neoplasia [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]</p></table-wrap-foot></table-wrap>
###xml 710 718 <span type="species:ncbi:9606">patients</span>
In the Netherlands, screening for mutations in a RET proto-oncogene is carried out in one central genetics laboratory at the University Medical Center Utrecht. Mutation analysis was performed by PCR amplification followed by direct sequence analysis of exons 10, 11, 14, 13, 15, and 16 of the RET proto-oncogene. Sporadic cases of MTC were identified by mutation analysis of RET exons 15 and 16 in DNA isolated from tumor samples, following a normal RET mutation screening result on DNA from peripheral blood. All results of RET mutation screening were confirmed on a duplicate DNA sample. (PCR conditions and oligonucleotide primer sequences are available upon request from RBL.) Based on the affected codon, patients were stratified into three levels of risk of developing MTC according to the 2001 guidelines [11]: standard risk (level 1; codons 768, 790, 791, 804, and 891), high risk (level 2; codons 630, 634, 609, 611, 618, and 620), and very high risk (level 3; codons 918, 883, and 922) (Table 1) [15].Table 1Risk level for MTC based on codon mutationRisk levelCodonRecommended age of surgery1Standard risk768, 790, 791, 804, and 8915-10 years2High risk630, 634, 609, 611, 618, and 620<5 years3Very high risk918, 883, and 922<6 monthsRisk level of MTC based on the 1999 consensus statement from the Seventh International Workshop on Multiple Endocrine Neoplasia [11, 15]
###end p 24
###begin p 25
Risk level for MTC based on codon mutation
###end p 25
###begin p 26
###xml 129 131 129 131 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 133 135 133 135 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
Risk level of MTC based on the 1999 consensus statement from the Seventh International Workshop on Multiple Endocrine Neoplasia [11, 15]
###end p 26
###begin title 27
Pathological examination and tumor staging
###end title 27
###begin p 28
###xml 989 990 989 990 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
Pathological examination of the thyroid specimens was performed separately at each hospital. In general, the thyroid specimen was fixed and transversally laminated in thin sections, which were then prepared for light microscopy. The transition zone between the upper and the middle third of the thyroid lobes was the focus of attention, as C cells are normally situated in this area. The sections were investigated for the presence of C cells; characterization of cytoplasmic levels of calcitonin, chromogranin, and carcinoembryonic antigen (CEA); destructions of follicles; and amyloidal formation and invasion of vessels and or nerves by these cells. C-cell hyperplasia was diagnosed when more than 7 C cells per follicle were present, there were clusters of C cells, or more than 20 C cells were observed per field. MTC was diagnosed in case of atypia of C cells and their nuclei in combination with follicular basal membrane destruction as a sign of infiltrative C-cell proliferation [5].
###end p 28
###begin title 29
Statistical analysis
###end title 29
###begin p 30
###xml 403 404 401 402 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 503 504 501 502 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 575 576 573 574 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">U</italic>
###xml 843 844 841 842 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1314 1317 1312 1315 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 1346 1349 1344 1347 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 1368 1370 1366 1368 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 103 111 <span type="species:ncbi:9606">children</span>
###xml 248 256 <span type="species:ncbi:9606">Patients</span>
###xml 1110 1117 <span type="species:ncbi:9606">patient</span>
Statistical analysis was performed using SPSS 16 (SPSS Inc., Chicago, IL). In this case control study, children with persistent or recurrent MTC were identified. Their exposure to possible prognostic factors was compared with those who were cured. Patients with C-cell hyperplasia were excluded from the analysis. Associations between categorical variables were evaluated with univariate analysis by chi2 analysis, and the in case of a sample size of 5 or fewer, by the Fischer' s exact test. Student's t test was used to analyze differences in mean values, the Mann-Whitney U test was used for differences in median values, and the ANOVA test was used for comparison of multiple groups. The correlation between factors was studied. A binary logistic regression analysis was performed to determine factors associated with recurrent disease. A p value of less than 0.05 was considered to be significant. Factors included in the multivariate analysis were age at surgery, the affected codon, the risk level 1, 2, or 3, presence of lymph node metastasis, and preoperative calcitonin levels. Furthermore, for each patient it was determined whether surgery had been performed at an appropriate age as recommended by the guidelines (age-appropriate prophylactic surgery) and if the surgery had been performed in the pre-RET era (before 1994) or in the RET era (after 1994) [11]. This factor was included in the analysis as well.
###end p 30
###begin title 31
Results
###end title 31
###begin p 32
###xml 137 138 137 138 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 139 146 139 146 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 146 169 146 169 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="33">Patient characteristics</p>
###xml 146 169 146 169 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="33">Patient characteristics</p></caption>
###xml 169 169 169 169 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 169 176 169 176 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Overall</th>
###xml 180 183 180 183 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 189 190 189 190 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 176 202 176 202 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Pre-<italic>RET</italic> era (<italic>n</italic>&#160;=&#160;25) (27%)</th>
###xml 202 205 202 205 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 211 212 211 212 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 202 224 202 224 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>RET</italic> era (<italic>n</italic>&#160;=&#160;68) (73%)</th>
###xml 224 225 224 225 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 231 232 231 232 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 224 232 224 232 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>p</italic> value<sup>a</sup></th>
###xml 169 232 169 232 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left"/><th align="left">Overall</th><th align="left">Pre-<italic>RET</italic> era (<italic>n</italic>&#160;=&#160;25) (27%)</th><th align="left"><italic>RET</italic> era (<italic>n</italic>&#160;=&#160;68) (73%)</th><th align="left"><italic>p</italic> value<sup>a</sup></th></tr>
###xml 169 232 169 232 <thead xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left"/><th align="left">Overall</th><th align="left">Pre-<italic>RET</italic> era (<italic>n</italic>&#160;=&#160;25) (27%)</th><th align="left"><italic>RET</italic> era (<italic>n</italic>&#160;=&#160;68) (73%)</th><th align="left"><italic>p</italic> value<sup>a</sup></th></tr></thead>
###xml 245 246 245 246 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 232 251 232 251 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Male:Female [<italic>n</italic> (%)]</td>
###xml 251 268 251 268 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">38 (41%):55 (59%)</td>
###xml 268 268 268 268 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 268 268 268 268 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 268 268 268 268 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 232 268 232 268 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Male:Female [<italic>n</italic> (%)]</td><td align="left">38 (41%):55 (59%)</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 268 292 268 292 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Median age (years) (IQR)</td>
###xml 292 306 292 306 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">8.9 (5.7&#8211;12.6)</td>
###xml 306 327 306 327 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">10.6&#160;years (7.4&#8211;13.2)</td>
###xml 327 341 327 341 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">7.8 (5.3&#8211;12.2)</td>
###xml 341 346 341 346 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.022</td>
###xml 268 346 268 346 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Median age (years) (IQR)</td><td align="left">8.9 (5.7&#8211;12.6)</td><td align="left">10.6&#160;years (7.4&#8211;13.2)</td><td align="left">7.8 (5.3&#8211;12.2)</td><td align="left">0.022</td></tr>
###xml 346 376 346 376 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Median follow-up (years) (IQR)</td>
###xml 376 384 376 384 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">7 (3&#8211;11)</td>
###xml 384 384 384 384 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 384 384 384 384 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 384 384 384 384 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 346 384 346 384 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Median follow-up (years) (IQR)</td><td align="left">7 (3&#8211;11)</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 391 392 391 392 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 384 397 384 397 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="5">Codon [<italic>n</italic> (%)]</td>
###xml 384 397 384 397 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="5">Codon [<italic>n</italic> (%)]</td></tr>
###xml 397 401 397 401 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;634</td>
###xml 401 409 401 409 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">62 (67%)</td>
###xml 409 409 409 409 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 409 409 409 409 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 409 409 409 409 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 397 409 397 409 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;634</td><td align="left">62 (67%)</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 409 422 409 420 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;Cys &#8594; Arg</td>
###xml 422 424 420 422 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">37</td>
###xml 424 424 422 422 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 424 424 422 422 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 424 424 422 422 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 409 424 409 422 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;Cys &#8594; Arg</td><td align="left">37</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 424 437 422 433 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;Cys &#8594; Gly</td>
###xml 437 438 433 434 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">9</td>
###xml 438 438 434 434 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 438 438 434 434 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 438 438 434 434 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 424 438 422 434 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;Cys &#8594; Gly</td><td align="left">9</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 438 451 434 445 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;Cys &#8594; Tyr</td>
###xml 451 452 445 446 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">8</td>
###xml 452 452 446 446 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 452 452 446 446 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 452 452 446 446 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 438 452 434 446 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;Cys &#8594; Tyr</td><td align="left">8</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 452 465 446 457 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;Cys &#8594; Trp</td>
###xml 465 466 457 458 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">8</td>
###xml 466 466 458 458 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 466 466 458 458 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 466 466 458 458 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 452 466 446 458 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;Cys &#8594; Trp</td><td align="left">8</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 466 470 458 462 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;620</td>
###xml 470 476 462 468 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3 (3%)</td>
###xml 476 476 468 468 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 476 476 468 468 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 476 476 468 468 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 466 476 458 468 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;620</td><td align="left">3 (3%)</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 476 489 468 479 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;Cys &#8594; Arg</td>
###xml 489 490 479 480 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">3</td>
###xml 490 490 480 480 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 490 490 480 480 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 490 490 480 480 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 476 490 468 480 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;Cys &#8594; Arg</td><td char="." align="left">3</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 490 494 480 484 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;611</td>
###xml 494 501 484 491 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">9 (10%)</td>
###xml 501 501 491 491 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 501 501 491 491 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 501 501 491 491 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 490 501 480 491 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;611</td><td char="." align="left">9 (10%)</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 501 514 491 502 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;Cys &#8594; Tyr</td>
###xml 514 515 502 503 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">9</td>
###xml 515 515 503 503 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 515 515 503 503 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 515 515 503 503 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 501 515 491 503 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;Cys &#8594; Tyr</td><td char="." align="left">9</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 515 519 503 507 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;618</td>
###xml 519 527 507 515 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">10 (11%)</td>
###xml 527 527 515 515 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 527 527 515 515 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 527 527 515 515 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 515 527 503 515 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;618</td><td char="." align="left">10 (11%)</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 527 540 515 526 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;Cys &#8594; Ser</td>
###xml 540 541 526 527 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">8</td>
###xml 541 541 527 527 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 541 541 527 527 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 541 541 527 527 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 527 541 515 527 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;Cys &#8594; Ser</td><td char="." align="left">8</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 541 554 527 538 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;Cys &#8594; Tyr</td>
###xml 554 555 538 539 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">1</td>
###xml 555 555 539 539 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 555 555 539 539 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 555 555 539 539 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 541 555 527 539 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;Cys &#8594; Tyr</td><td char="." align="left">1</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 555 568 539 550 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;Cys &#8594; Arg</td>
###xml 568 569 550 551 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">1</td>
###xml 569 569 551 551 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 569 569 551 551 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 569 569 551 551 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 555 569 539 551 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;Cys &#8594; Arg</td><td char="." align="left">1</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 569 573 551 555 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;918</td>
###xml 573 579 555 561 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">6 (6%)</td>
###xml 579 579 561 561 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 579 579 561 561 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 579 579 561 561 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 569 579 551 561 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;918</td><td char="." align="left">6 (6%)</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 579 592 561 572 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;Met &#8594; Thr</td>
###xml 592 593 572 573 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">6</td>
###xml 593 593 573 573 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 593 593 573 573 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 593 593 573 573 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 579 593 561 573 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;Met &#8594; Thr</td><td char="." align="left">6</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 593 610 573 588 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;804 Val &#8594; Leu</td>
###xml 610 616 588 594 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">1 (1%)</td>
###xml 616 616 594 594 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 616 616 594 594 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 616 616 594 594 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 593 616 573 594 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;804 Val &#8594; Leu</td><td char="." align="left">1 (1%)</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 616 625 594 603 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;Unknown</td>
###xml 625 631 603 609 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">2 (2%)</td>
###xml 631 631 609 609 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 631 631 609 609 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 631 631 609 609 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 616 631 594 609 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;Unknown</td><td char="." align="left">2 (2%)</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 643 644 621 622 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 631 645 609 623 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Risk level (<italic>n</italic>)</td>
###xml 645 645 623 623 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 645 645 623 623 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 645 645 623 623 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 645 645 623 623 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 631 645 609 623 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Risk level (<italic>n</italic>)</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 645 663 623 641 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;1 (standard risk)</td>
###xml 663 664 641 642 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">1</td>
###xml 664 664 642 642 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 664 664 642 642 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 664 664 642 642 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 645 664 623 642 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;1 (standard risk)</td><td char="." align="left">1</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 664 678 642 656 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;2 (high risk)</td>
###xml 678 680 656 658 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">84</td>
###xml 680 680 658 658 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 680 680 658 658 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 680 680 658 658 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 664 680 642 658 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;2 (high risk)</td><td char="." align="left">84</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 680 699 658 677 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;3 (very high risk)</td>
###xml 699 700 677 678 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">6</td>
###xml 700 700 678 678 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 700 700 678 678 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 700 700 678 678 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 680 700 658 678 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;3 (very high risk)</td><td char="." align="left">6</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 700 708 678 686 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;Unknown</td>
###xml 708 709 686 687 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">2</td>
###xml 709 709 687 687 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 709 709 687 687 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 709 709 687 687 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 700 709 678 687 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;Unknown</td><td char="." align="left">2</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 739 740 717 718 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 709 740 687 718 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Preoperative calcitonin levels<sup>b</sup></td>
###xml 740 740 718 718 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 740 740 718 718 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 740 740 718 718 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 740 742 718 720 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">ns</td>
###xml 709 742 687 720 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Preoperative calcitonin levels<sup>b</sup></td><td align="left"/><td align="left"/><td align="left"/><td align="left">ns</td></tr>
###xml 742 749 720 727 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;Normal</td>
###xml 749 757 727 735 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">47 (51%)</td>
###xml 759 760 737 738 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 757 760 735 738 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">14<sup>c</sup></td>
###xml 760 762 738 740 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">33</td>
###xml 762 762 740 740 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 742 762 720 740 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;Normal</td><td char="." align="left">47 (51%)</td><td align="left">14<sup>c</sup></td><td char="." align="left">33</td><td align="left"/></tr>
###xml 762 771 740 749 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;Elevated</td>
###xml 771 779 749 757 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">43 (46%)</td>
###xml 779 781 757 759 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">10</td>
###xml 781 783 759 761 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">33</td>
###xml 783 783 761 761 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 762 783 740 761 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;Elevated</td><td char="." align="left">43 (46%)</td><td align="left">10</td><td char="." align="left">33</td><td align="left"/></tr>
###xml 783 791 761 769 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;Unknown</td>
###xml 791 797 769 775 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">3 (3%)</td>
###xml 797 797 775 775 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 797 797 775 775 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 797 797 775 775 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 783 797 761 775 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;Unknown</td><td char="." align="left">3 (3%)</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 797 820 775 798 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Age-appropriate surgery</td>
###xml 820 820 798 798 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 820 820 798 798 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 820 820 798 798 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 820 825 798 803 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.004</td>
###xml 797 825 775 803 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Age-appropriate surgery</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.004</td></tr>
###xml 825 829 803 807 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;Yes</td>
###xml 829 837 807 815 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">22 (24%)</td>
###xml 837 838 815 816 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 838 840 816 818 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">21</td>
###xml 840 840 818 818 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 825 840 803 818 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;Yes</td><td char="." align="left">22 (24%)</td><td align="left">1</td><td char="." align="left">21</td><td align="left"/></tr>
###xml 840 843 818 821 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;No</td>
###xml 843 851 821 829 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">71 (76%)</td>
###xml 851 853 829 831 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">24</td>
###xml 853 855 831 833 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">47</td>
###xml 855 855 833 833 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 840 855 818 833 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;No</td><td char="." align="left">71 (76%)</td><td align="left">24</td><td char="." align="left">47</td><td align="left"/></tr>
###xml 855 864 833 842 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="5">Histology</td>
###xml 855 864 833 842 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="5">Histology</td></tr>
###xml 864 883 842 861 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;C-cell hyperplasia</td>
###xml 883 891 861 869 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">30 (32%)</td>
###xml 891 892 869 870 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">7</td>
###xml 892 894 870 872 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">22</td>
###xml 894 896 872 874 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">ns</td>
###xml 864 896 842 874 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;C-cell hyperplasia</td><td char="." align="left">30 (32%)</td><td align="left">7</td><td align="left">22</td><td align="left">ns</td></tr>
###xml 896 924 874 902 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;Medullary thyroid carcinoma</td>
###xml 924 932 902 910 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">61 (66%)</td>
###xml 932 934 910 912 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">18</td>
###xml 934 936 912 914 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">43</td>
###xml 936 936 914 914 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 896 936 874 914 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;Medullary thyroid carcinoma</td><td char="." align="left">61 (66%)</td><td align="left">18</td><td align="left">43</td><td align="left"/></tr>
###xml 936 953 914 931 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;Normal histology</td>
###xml 953 959 931 937 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="left">2 (2%)</td>
###xml 959 959 937 937 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 959 960 937 938 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2</td>
###xml 960 960 938 938 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 936 960 914 938 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;Normal histology</td><td char="." align="left">2 (2%)</td><td align="left"/><td align="left">2</td><td align="left"/></tr>
###xml 960 981 938 959 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Lymph node metastasis</td>
###xml 981 987 959 965 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">8 (9%)</td>
###xml 987 988 965 966 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5</td>
###xml 988 989 966 967 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3</td>
###xml 989 993 967 971 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.02</td>
###xml 960 993 938 971 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Lymph node metastasis</td><td align="left">8 (9%)</td><td align="left">5</td><td align="left">3</td><td align="left">0.02</td></tr>
###xml 993 1020 971 998 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="5">Disease status at follow-up</td>
###xml 993 1020 971 998 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="5">Disease status at follow-up</td></tr>
###xml 1020 1033 998 1011 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;Disease free</td>
###xml 1033 1041 1011 1019 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">75 (81%)</td>
###xml 1041 1041 1019 1019 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1041 1041 1019 1019 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1041 1041 1019 1019 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1020 1041 998 1019 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;Disease free</td><td align="left">75 (81%)</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 1041 1059 1019 1037 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;Recurrent disease</td>
###xml 1059 1067 1037 1045 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">16 (17%)</td>
###xml 1067 1067 1045 1045 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1067 1067 1045 1045 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1067 1067 1045 1045 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1041 1067 1019 1045 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;Recurrent disease</td><td align="left">16 (17%)</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 1067 1089 1045 1067 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;Disease-related death</td>
###xml 1089 1090 1067 1068 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 1090 1090 1068 1068 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1090 1090 1068 1068 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1090 1090 1068 1068 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1067 1090 1045 1068 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;Disease-related death</td><td align="left">1</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 1090 1098 1068 1076 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;Unknown</td>
###xml 1098 1099 1076 1077 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2</td>
###xml 1099 1099 1077 1077 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1099 1099 1077 1077 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1099 1099 1077 1077 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1090 1099 1068 1077 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;Unknown</td><td align="left">2</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 232 1099 232 1077 <tbody xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">Male:Female [<italic>n</italic> (%)]</td><td align="left">38 (41%):55 (59%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Median age (years) (IQR)</td><td align="left">8.9 (5.7&#8211;12.6)</td><td align="left">10.6&#160;years (7.4&#8211;13.2)</td><td align="left">7.8 (5.3&#8211;12.2)</td><td align="left">0.022</td></tr><tr><td align="left">Median follow-up (years) (IQR)</td><td align="left">7 (3&#8211;11)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="5">Codon [<italic>n</italic> (%)]</td></tr><tr><td align="left">&#160;634</td><td align="left">62 (67%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Arg</td><td align="left">37</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Gly</td><td align="left">9</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Tyr</td><td align="left">8</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Trp</td><td align="left">8</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;620</td><td align="left">3 (3%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Arg</td><td char="." align="left">3</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;611</td><td char="." align="left">9 (10%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Tyr</td><td char="." align="left">9</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;618</td><td char="." align="left">10 (11%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Ser</td><td char="." align="left">8</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Tyr</td><td char="." align="left">1</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Arg</td><td char="." align="left">1</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;918</td><td char="." align="left">6 (6%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Met &#8594; Thr</td><td char="." align="left">6</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;804 Val &#8594; Leu</td><td char="." align="left">1 (1%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Unknown</td><td char="." align="left">2 (2%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Risk level (<italic>n</italic>)</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;1 (standard risk)</td><td char="." align="left">1</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;2 (high risk)</td><td char="." align="left">84</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;3 (very high risk)</td><td char="." align="left">6</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;Unknown</td><td char="." align="left">2</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Preoperative calcitonin levels<sup>b</sup></td><td align="left"/><td align="left"/><td align="left"/><td align="left">ns</td></tr><tr><td align="left">&#160;Normal</td><td char="." align="left">47 (51%)</td><td align="left">14<sup>c</sup></td><td char="." align="left">33</td><td align="left"/></tr><tr><td align="left">&#160;Elevated</td><td char="." align="left">43 (46%)</td><td align="left">10</td><td char="." align="left">33</td><td align="left"/></tr><tr><td align="left">&#160;Unknown</td><td char="." align="left">3 (3%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Age-appropriate surgery</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.004</td></tr><tr><td align="left">&#160;Yes</td><td char="." align="left">22 (24%)</td><td align="left">1</td><td char="." align="left">21</td><td align="left"/></tr><tr><td align="left">&#160;No</td><td char="." align="left">71 (76%)</td><td align="left">24</td><td char="." align="left">47</td><td align="left"/></tr><tr><td align="left" colspan="5">Histology</td></tr><tr><td align="left">&#160;C-cell hyperplasia</td><td char="." align="left">30 (32%)</td><td align="left">7</td><td align="left">22</td><td align="left">ns</td></tr><tr><td align="left">&#160;Medullary thyroid carcinoma</td><td char="." align="left">61 (66%)</td><td align="left">18</td><td align="left">43</td><td align="left"/></tr><tr><td align="left">&#160;Normal histology</td><td char="." align="left">2 (2%)</td><td align="left"/><td align="left">2</td><td align="left"/></tr><tr><td align="left">Lymph node metastasis</td><td align="left">8 (9%)</td><td align="left">5</td><td align="left">3</td><td align="left">0.02</td></tr><tr><td align="left" colspan="5">Disease status at follow-up</td></tr><tr><td align="left">&#160;Disease free</td><td align="left">75 (81%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;Recurrent disease</td><td align="left">16 (17%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;Disease-related death</td><td align="left">1</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;Unknown</td><td align="left">2</td><td align="left"/><td align="left"/><td align="left"/></tr></tbody>
###xml 169 1099 169 1077 <table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Overall</th><th align="left">Pre-<italic>RET</italic> era (<italic>n</italic>&#160;=&#160;25) (27%)</th><th align="left"><italic>RET</italic> era (<italic>n</italic>&#160;=&#160;68) (73%)</th><th align="left"><italic>p</italic> value<sup>a</sup></th></tr></thead><tbody><tr><td align="left">Male:Female [<italic>n</italic> (%)]</td><td align="left">38 (41%):55 (59%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Median age (years) (IQR)</td><td align="left">8.9 (5.7&#8211;12.6)</td><td align="left">10.6&#160;years (7.4&#8211;13.2)</td><td align="left">7.8 (5.3&#8211;12.2)</td><td align="left">0.022</td></tr><tr><td align="left">Median follow-up (years) (IQR)</td><td align="left">7 (3&#8211;11)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="5">Codon [<italic>n</italic> (%)]</td></tr><tr><td align="left">&#160;634</td><td align="left">62 (67%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Arg</td><td align="left">37</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Gly</td><td align="left">9</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Tyr</td><td align="left">8</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Trp</td><td align="left">8</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;620</td><td align="left">3 (3%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Arg</td><td char="." align="left">3</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;611</td><td char="." align="left">9 (10%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Tyr</td><td char="." align="left">9</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;618</td><td char="." align="left">10 (11%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Ser</td><td char="." align="left">8</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Tyr</td><td char="." align="left">1</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Arg</td><td char="." align="left">1</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;918</td><td char="." align="left">6 (6%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Met &#8594; Thr</td><td char="." align="left">6</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;804 Val &#8594; Leu</td><td char="." align="left">1 (1%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Unknown</td><td char="." align="left">2 (2%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Risk level (<italic>n</italic>)</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;1 (standard risk)</td><td char="." align="left">1</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;2 (high risk)</td><td char="." align="left">84</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;3 (very high risk)</td><td char="." align="left">6</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;Unknown</td><td char="." align="left">2</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Preoperative calcitonin levels<sup>b</sup></td><td align="left"/><td align="left"/><td align="left"/><td align="left">ns</td></tr><tr><td align="left">&#160;Normal</td><td char="." align="left">47 (51%)</td><td align="left">14<sup>c</sup></td><td char="." align="left">33</td><td align="left"/></tr><tr><td align="left">&#160;Elevated</td><td char="." align="left">43 (46%)</td><td align="left">10</td><td char="." align="left">33</td><td align="left"/></tr><tr><td align="left">&#160;Unknown</td><td char="." align="left">3 (3%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Age-appropriate surgery</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.004</td></tr><tr><td align="left">&#160;Yes</td><td char="." align="left">22 (24%)</td><td align="left">1</td><td char="." align="left">21</td><td align="left"/></tr><tr><td align="left">&#160;No</td><td char="." align="left">71 (76%)</td><td align="left">24</td><td char="." align="left">47</td><td align="left"/></tr><tr><td align="left" colspan="5">Histology</td></tr><tr><td align="left">&#160;C-cell hyperplasia</td><td char="." align="left">30 (32%)</td><td align="left">7</td><td align="left">22</td><td align="left">ns</td></tr><tr><td align="left">&#160;Medullary thyroid carcinoma</td><td char="." align="left">61 (66%)</td><td align="left">18</td><td align="left">43</td><td align="left"/></tr><tr><td align="left">&#160;Normal histology</td><td char="." align="left">2 (2%)</td><td align="left"/><td align="left">2</td><td align="left"/></tr><tr><td align="left">Lymph node metastasis</td><td align="left">8 (9%)</td><td align="left">5</td><td align="left">3</td><td align="left">0.02</td></tr><tr><td align="left" colspan="5">Disease status at follow-up</td></tr><tr><td align="left">&#160;Disease free</td><td align="left">75 (81%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;Recurrent disease</td><td align="left">16 (17%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;Disease-related death</td><td align="left">1</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;Unknown</td><td align="left">2</td><td align="left"/><td align="left"/><td align="left"/></tr></tbody></table>
###xml 1099 1101 1077 1079 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ns</italic>
###xml 1099 1117 1077 1095 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="34"><italic>ns</italic> not significant</p>
###xml 1117 1118 1095 1096 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1137 1140 1115 1118 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 1149 1152 1127 1130 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 1117 1156 1095 1134 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="35"><sup>a</sup>Comparison for pre-<italic>RET</italic> era and <italic>RET</italic> era</p>
###xml 1156 1157 1134 1135 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1156 1331 1134 1309 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="36"><sup>b</sup>The mean age of patients with normal calcitonin levels was 8.8&#160;years versus a mean age of 9.0&#160;years for patients with elevated calcitonin levels (not significantly different)</p>
###xml 1331 1332 1309 1310 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 1399 1402 1377 1380 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 1331 1589 1309 1567 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="37"><sup>c</sup>Eleven of the 14 patients with normal calcitonin levels in the pre-<italic>RET</italic> era were operated on in the transition period between 1993 and 1994. Genetic testing had become available in the UMCU at that time. Two of the other three patients had C-cell hyperplasia</p>
###xml 1099 1589 1077 1567 <table-wrap-foot xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="34"><italic>ns</italic> not significant</p><p textid="35"><sup>a</sup>Comparison for pre-<italic>RET</italic> era and <italic>RET</italic> era</p><p textid="36"><sup>b</sup>The mean age of patients with normal calcitonin levels was 8.8&#160;years versus a mean age of 9.0&#160;years for patients with elevated calcitonin levels (not significantly different)</p><p textid="37"><sup>c</sup>Eleven of the 14 patients with normal calcitonin levels in the pre-<italic>RET</italic> era were operated on in the transition period between 1993 and 1994. Genetic testing had become available in the UMCU at that time. Two of the other three patients had C-cell hyperplasia</p></table-wrap-foot>
###xml 139 1589 139 1567 <table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="33">Patient characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Overall</th><th align="left">Pre-<italic>RET</italic> era (<italic>n</italic>&#160;=&#160;25) (27%)</th><th align="left"><italic>RET</italic> era (<italic>n</italic>&#160;=&#160;68) (73%)</th><th align="left"><italic>p</italic> value<sup>a</sup></th></tr></thead><tbody><tr><td align="left">Male:Female [<italic>n</italic> (%)]</td><td align="left">38 (41%):55 (59%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Median age (years) (IQR)</td><td align="left">8.9 (5.7&#8211;12.6)</td><td align="left">10.6&#160;years (7.4&#8211;13.2)</td><td align="left">7.8 (5.3&#8211;12.2)</td><td align="left">0.022</td></tr><tr><td align="left">Median follow-up (years) (IQR)</td><td align="left">7 (3&#8211;11)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="5">Codon [<italic>n</italic> (%)]</td></tr><tr><td align="left">&#160;634</td><td align="left">62 (67%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Arg</td><td align="left">37</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Gly</td><td align="left">9</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Tyr</td><td align="left">8</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Trp</td><td align="left">8</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;620</td><td align="left">3 (3%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Arg</td><td char="." align="left">3</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;611</td><td char="." align="left">9 (10%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Tyr</td><td char="." align="left">9</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;618</td><td char="." align="left">10 (11%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Ser</td><td char="." align="left">8</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Tyr</td><td char="." align="left">1</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Cys &#8594; Arg</td><td char="." align="left">1</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;918</td><td char="." align="left">6 (6%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Met &#8594; Thr</td><td char="." align="left">6</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;804 Val &#8594; Leu</td><td char="." align="left">1 (1%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;Unknown</td><td char="." align="left">2 (2%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Risk level (<italic>n</italic>)</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;1 (standard risk)</td><td char="." align="left">1</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;2 (high risk)</td><td char="." align="left">84</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;3 (very high risk)</td><td char="." align="left">6</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;Unknown</td><td char="." align="left">2</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Preoperative calcitonin levels<sup>b</sup></td><td align="left"/><td align="left"/><td align="left"/><td align="left">ns</td></tr><tr><td align="left">&#160;Normal</td><td char="." align="left">47 (51%)</td><td align="left">14<sup>c</sup></td><td char="." align="left">33</td><td align="left"/></tr><tr><td align="left">&#160;Elevated</td><td char="." align="left">43 (46%)</td><td align="left">10</td><td char="." align="left">33</td><td align="left"/></tr><tr><td align="left">&#160;Unknown</td><td char="." align="left">3 (3%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Age-appropriate surgery</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.004</td></tr><tr><td align="left">&#160;Yes</td><td char="." align="left">22 (24%)</td><td align="left">1</td><td char="." align="left">21</td><td align="left"/></tr><tr><td align="left">&#160;No</td><td char="." align="left">71 (76%)</td><td align="left">24</td><td char="." align="left">47</td><td align="left"/></tr><tr><td align="left" colspan="5">Histology</td></tr><tr><td align="left">&#160;C-cell hyperplasia</td><td char="." align="left">30 (32%)</td><td align="left">7</td><td align="left">22</td><td align="left">ns</td></tr><tr><td align="left">&#160;Medullary thyroid carcinoma</td><td char="." align="left">61 (66%)</td><td align="left">18</td><td align="left">43</td><td align="left"/></tr><tr><td align="left">&#160;Normal histology</td><td char="." align="left">2 (2%)</td><td align="left"/><td align="left">2</td><td align="left"/></tr><tr><td align="left">Lymph node metastasis</td><td align="left">8 (9%)</td><td align="left">5</td><td align="left">3</td><td align="left">0.02</td></tr><tr><td align="left" colspan="5">Disease status at follow-up</td></tr><tr><td align="left">&#160;Disease free</td><td align="left">75 (81%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;Recurrent disease</td><td align="left">16 (17%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;Disease-related death</td><td align="left">1</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;Unknown</td><td align="left">2</td><td align="left"/><td align="left"/><td align="left"/></tr></tbody></table><table-wrap-foot><p textid="34"><italic>ns</italic> not significant</p><p textid="35"><sup>a</sup>Comparison for pre-<italic>RET</italic> era and <italic>RET</italic> era</p><p textid="36"><sup>b</sup>The mean age of patients with normal calcitonin levels was 8.8&#160;years versus a mean age of 9.0&#160;years for patients with elevated calcitonin levels (not significantly different)</p><p textid="37"><sup>c</sup>Eleven of the 14 patients with normal calcitonin levels in the pre-<italic>RET</italic> era were operated on in the transition period between 1993 and 1994. Genetic testing had become available in the UMCU at that time. Two of the other three patients had C-cell hyperplasia</p></table-wrap-foot></table-wrap>
###xml 10 18 <span type="species:ncbi:9606">patients</span>
###xml 1173 1181 <span type="species:ncbi:9606">patients</span>
###xml 1261 1269 <span type="species:ncbi:9606">patients</span>
###xml 1349 1357 <span type="species:ncbi:9606">patients</span>
###xml 1558 1566 <span type="species:ncbi:9606">patients</span>
Of the 93 patients identified, 38 (41%) were male and 55 (59%) female. Demographic, surgical, and follow-up data are summarized in Table 2.Table 2Patient characteristicsOverallPre-RET era (n = 25) (27%)RET era (n = 68) (73%)p valueaMale:Female [n (%)]38 (41%):55 (59%)Median age (years) (IQR)8.9 (5.7-12.6)10.6 years (7.4-13.2)7.8 (5.3-12.2)0.022Median follow-up (years) (IQR)7 (3-11)Codon [n (%)] 63462 (67%)  Cys --> Arg37  Cys --> Gly9  Cys --> Tyr8  Cys --> Trp8 6203 (3%)  Cys --> Arg3 6119 (10%)  Cys --> Tyr9 61810 (11%)  Cys --> Ser8  Cys --> Tyr1  Cys --> Arg1 9186 (6%)  Met --> Thr6  804 Val --> Leu1 (1%)  Unknown2 (2%)Risk level (n) 1 (standard risk)1 2 (high risk)84 3 (very high risk)6 Unknown2Preoperative calcitonin levelsbns Normal47 (51%)14c33 Elevated43 (46%)1033 Unknown3 (3%)Age-appropriate surgery0.004 Yes22 (24%)121 No71 (76%)2447Histology C-cell hyperplasia30 (32%)722ns Medullary thyroid carcinoma61 (66%)1843 Normal histology2 (2%)2Lymph node metastasis8 (9%)530.02Disease status at follow-up Disease free75 (81%) Recurrent disease16 (17%) Disease-related death1 Unknown2ns not significantaComparison for pre-RET era and RET erabThe mean age of patients with normal calcitonin levels was 8.8 years versus a mean age of 9.0 years for patients with elevated calcitonin levels (not significantly different)cEleven of the 14 patients with normal calcitonin levels in the pre-RET era were operated on in the transition period between 1993 and 1994. Genetic testing had become available in the UMCU at that time. Two of the other three patients had C-cell hyperplasia
###end p 32
###begin p 33
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient characteristics
###end p 33
###begin p 34
###xml 0 2 0 2 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ns</italic>
ns not significant
###end p 34
###begin p 35
###xml 0 1 0 1 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 20 23 20 23 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 32 35 32 35 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
aComparison for pre-RET era and RET era
###end p 35
###begin p 36
###xml 0 1 0 1 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 17 25 <span type="species:ncbi:9606">patients</span>
###xml 105 113 <span type="species:ncbi:9606">patients</span>
bThe mean age of patients with normal calcitonin levels was 8.8 years versus a mean age of 9.0 years for patients with elevated calcitonin levels (not significantly different)
###end p 36
###begin p 37
###xml 0 1 0 1 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 68 71 68 71 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 18 26 <span type="species:ncbi:9606">patients</span>
###xml 227 235 <span type="species:ncbi:9606">patients</span>
cEleven of the 14 patients with normal calcitonin levels in the pre-RET era were operated on in the transition period between 1993 and 1994. Genetic testing had become available in the UMCU at that time. Two of the other three patients had C-cell hyperplasia
###end p 37
###begin p 38
###xml 43 44 43 44 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 101 102 101 102 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 475 476 475 476 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 553 556 553 556 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 572 575 572 575 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 71 79 <span type="species:ncbi:9606">patients</span>
###xml 159 167 <span type="species:ncbi:9606">patients</span>
###xml 225 233 <span type="species:ncbi:9606">patients</span>
###xml 249 257 <span type="species:ncbi:9606">patients</span>
###xml 273 281 <span type="species:ncbi:9606">patients</span>
###xml 297 305 <span type="species:ncbi:9606">patients</span>
###xml 325 332 <span type="species:ncbi:9606">patient</span>
###xml 342 350 <span type="species:ncbi:9606">patients</span>
###xml 478 485 <span type="species:ncbi:9606">patient</span>
###xml 521 529 <span type="species:ncbi:9606">patients</span>
The majority of cases had MEN 2A syndrome (n = 87, 94%). The remaining patients had MEN 2B syndrome (n = 6, 6%). Mutation analysis revealed that codon 634 (62 patients) was most frequently affected, followed by codon 618 (10 patients), codon 611 (9 patients), codon 918 (6 patients), codon 620 (3 patients), and codon 804 (1 patient). In two patients, who underwent surgery in the early 1980s, the genetic mutation could not be retrieved from the national database. In Table 2, patient characteristics are also given for patients operated on in the pre-RET era and in the RET era.
###end p 38
###begin p 39
###xml 116 119 116 119 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 165 168 165 168 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 470 471 470 471 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 562 565 562 565 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 580 583 580 583 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 671 674 671 674 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 851 852 851 852 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 22 30 <span type="species:ncbi:9606">patients</span>
###xml 75 83 <span type="species:ncbi:9606">Patients</span>
###xml 140 148 <span type="species:ncbi:9606">patients</span>
###xml 254 262 <span type="species:ncbi:9606">patients</span>
###xml 328 336 <span type="species:ncbi:9606">patients</span>
###xml 480 488 <span type="species:ncbi:9606">patients</span>
###xml 542 550 <span type="species:ncbi:9606">patients</span>
###xml 602 610 <span type="species:ncbi:9606">patients</span>
###xml 799 807 <span type="species:ncbi:9606">patients</span>
###xml 890 898 <span type="species:ncbi:9606">patients</span>
The median age of all patients at surgery was 8.9 years (IQR = 5.7-12.25). Patients who were operated on in the pre-RET era were older than patients operated in the RET era (10.6 vs. 7.8 years). A preoperatively elevated calcitonin level was found in 43 patients (46%). A central compartment neck dissection was performed in 26 patients (28%) and a modified lateral neck dissection in 8 (9%), in most cases because of evident intraoperative lymph node metastases (Table 2). Seven patients (7%) developed definitive hypoparathyroidism (15% of patients in the pre-RET era and 4% in RET era) and two (2%) patients suffered from permanent laryngeal nerve damage (none in the RET era). No association between the age at surgery, a central neck dissection, or the complication rate was found. None of the patients operated on who were younger than 5 years (n = 14) developed a complication. Five patients were not operated on prophylactically because four already had a clinically apparent tumor and another a palpable lymph node at the time of surgical intervention.
###end p 39
###begin p 40
###xml 273 274 273 274 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab3" ref-type="table">3</xref>
###xml 498 501 498 501 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 514 517 514 517 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 651 654 651 654 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 672 673 672 673 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 683 690 683 690 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;3</label>
###xml 690 785 690 785 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="41">Factors associated with residual or recurrent disease in patients with MTC; univariate analysis</p>
###xml 690 785 690 785 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="41">Factors associated with residual or recurrent disease in patients with MTC; univariate analysis</p></caption>
###xml 785 791 785 791 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Factor</th>
###xml 819 820 819 820 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 833 834 833 834 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 791 838 791 838 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Residual/recurrent disease (<italic>n</italic>&#160;=&#160;16, 27%) (<italic>n</italic>, %)</th>
###xml 881 882 881 882 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 895 896 895 896 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 838 900 838 900 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No evidence of residual/recurrent disease (<italic>n</italic>&#160;=&#160;44, 73%) (<italic>n</italic>, %)</th>
###xml 918 919 918 919 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 900 925 900 925 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Likelihood-ratio, <italic>p</italic> value</th>
###xml 785 925 785 925 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Factor</th><th align="left">Residual/recurrent disease (<italic>n</italic>&#160;=&#160;16, 27%) (<italic>n</italic>, %)</th><th align="left">No evidence of residual/recurrent disease (<italic>n</italic>&#160;=&#160;44, 73%) (<italic>n</italic>, %)</th><th align="left">Likelihood-ratio, <italic>p</italic> value</th></tr>
###xml 785 925 785 925 <thead xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left">Factor</th><th align="left">Residual/recurrent disease (<italic>n</italic>&#160;=&#160;16, 27%) (<italic>n</italic>, %)</th><th align="left">No evidence of residual/recurrent disease (<italic>n</italic>&#160;=&#160;44, 73%) (<italic>n</italic>, %)</th><th align="left">Likelihood-ratio, <italic>p</italic> value</th></tr></thead>
###xml 925 964 925 964 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Preoperative calcitonin levels elevated</td>
###xml 964 965 964 965 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 964 976 964 976 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>N</italic>&#160;=&#160;13 (81%)</td>
###xml 976 977 976 977 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 976 988 976 988 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>N</italic>&#160;=&#160;20 (46%)</td>
###xml 993 994 993 994 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 988 1002 988 1002 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">6.5, <italic>p</italic>&#160;=&#160;0.011</td>
###xml 925 1002 925 1002 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Preoperative calcitonin levels elevated</td><td align="left"><italic>N</italic>&#160;=&#160;13 (81%)</td><td align="left"><italic>N</italic>&#160;=&#160;20 (46%)</td><td align="left">6.5, <italic>p</italic>&#160;=&#160;0.011</td></tr>
###xml 1007 1008 1007 1008 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1002 1008 1002 1008 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="6">Codon<sup>a</sup></td>
###xml 1013 1014 1013 1014 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1008 1019 1008 1019 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">634, <italic>n</italic>&#160;=&#160;11</td>
###xml 1024 1025 1024 1025 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1019 1030 1019 1030 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">634, <italic>n</italic>&#160;=&#160;35</td>
###xml 1036 1037 1036 1037 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1030 1044 1030 1044 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="6">10.7, <italic>p</italic>&#160;=&#160;0.03</td>
###xml 1002 1044 1002 1044 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" rowspan="6">Codon<sup>a</sup></td><td align="left">634, <italic>n</italic>&#160;=&#160;11</td><td align="left">634, <italic>n</italic>&#160;=&#160;35</td><td align="left" rowspan="6">10.7, <italic>p</italic>&#160;=&#160;0.03</td></tr>
###xml 1049 1050 1049 1050 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1044 1054 1044 1054 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">918, <italic>n</italic>&#160;=&#160;4</td>
###xml 1059 1060 1059 1060 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1054 1064 1054 1064 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">618, <italic>n</italic>&#160;=&#160;3</td>
###xml 1044 1064 1044 1064 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">918, <italic>n</italic>&#160;=&#160;4</td><td align="left">618, <italic>n</italic>&#160;=&#160;3</td></tr>
###xml 1073 1074 1073 1074 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1064 1078 1064 1078 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Unknown, <italic>n</italic>&#160;=&#160;1</td>
###xml 1083 1084 1083 1084 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1078 1088 1078 1088 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">620, <italic>n</italic>&#160;=&#160;1</td>
###xml 1064 1088 1064 1088 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Unknown, <italic>n</italic>&#160;=&#160;1</td><td align="left">620, <italic>n</italic>&#160;=&#160;1</td></tr>
###xml 1088 1088 1088 1088 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1093 1094 1093 1094 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1088 1098 1088 1098 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">611, <italic>n</italic>&#160;=&#160;3</td>
###xml 1088 1098 1088 1098 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"/><td align="left">611, <italic>n</italic>&#160;=&#160;3</td></tr>
###xml 1098 1098 1098 1098 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1103 1104 1103 1104 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1098 1108 1098 1108 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">918, <italic>n</italic>&#160;=&#160;1</td>
###xml 1098 1108 1098 1108 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"/><td align="left">918, <italic>n</italic>&#160;=&#160;1</td></tr>
###xml 1108 1108 1108 1108 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1117 1118 1117 1118 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1108 1122 1108 1122 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Unknown, <italic>n</italic>&#160;=&#160;1</td>
###xml 1108 1122 1108 1122 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"/><td align="left">Unknown, <italic>n</italic>&#160;=&#160;1</td></tr>
###xml 1132 1133 1132 1133 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1122 1133 1122 1133 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Risk level<sup>b</sup></td>
###xml 1133 1133 1133 1133 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1133 1133 1133 1133 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1138 1139 1138 1139 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1133 1147 1133 1147 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="5">7.1, <italic>p</italic>&#160;=&#160;0.007</td>
###xml 1122 1147 1122 1147 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Risk level<sup>b</sup></td><td align="left"/><td align="left"/><td align="left" rowspan="5">7.1, <italic>p</italic>&#160;=&#160;0.007</td></tr>
###xml 1147 1149 1147 1149 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;1</td>
###xml 1149 1150 1149 1150 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1149 1154 1149 1154 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>n</italic>&#160;=&#160;0</td>
###xml 1154 1155 1154 1155 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1154 1159 1154 1159 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>n</italic>&#160;=&#160;0</td>
###xml 1147 1159 1147 1159 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;1</td><td align="left"><italic>n</italic>&#160;=&#160;0</td><td align="left"><italic>n</italic>&#160;=&#160;0</td></tr>
###xml 1159 1161 1159 1161 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;2</td>
###xml 1161 1162 1161 1162 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1161 1167 1161 1167 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>n</italic>&#160;=&#160;11</td>
###xml 1167 1168 1167 1168 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1167 1173 1167 1173 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>n</italic>&#160;=&#160;42</td>
###xml 1159 1173 1159 1173 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;2</td><td align="left"><italic>n</italic>&#160;=&#160;11</td><td align="left"><italic>n</italic>&#160;=&#160;42</td></tr>
###xml 1173 1175 1173 1175 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;3</td>
###xml 1175 1176 1175 1176 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1175 1180 1175 1180 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>n</italic>&#160;=&#160;4</td>
###xml 1180 1181 1180 1181 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1180 1185 1180 1185 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>n</italic>&#160;=&#160;1</td>
###xml 1173 1185 1173 1185 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;3</td><td align="left"><italic>n</italic>&#160;=&#160;4</td><td align="left"><italic>n</italic>&#160;=&#160;1</td></tr>
###xml 1185 1193 1185 1193 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;Unknown</td>
###xml 1193 1194 1193 1194 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1193 1198 1193 1198 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>n</italic>&#160;=&#160;1</td>
###xml 1198 1199 1198 1199 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1198 1203 1198 1203 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>n</italic>&#160;=&#160;1</td>
###xml 1185 1203 1185 1203 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;Unknown</td><td align="left"><italic>n</italic>&#160;=&#160;1</td><td align="left"><italic>n</italic>&#160;=&#160;1</td></tr>
###xml 1255 1256 1255 1256 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1203 1260 1203 1260 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Lymph node metastases at total thyroidectomy, total <italic>n</italic>&#160;=&#160;8</td>
###xml 1281 1282 1281 1282 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1260 1286 1260 1286 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Lymph nodes present, <italic>n</italic>&#160;=&#160;8</td>
###xml 1312 1313 1312 1313 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1286 1318 1286 1318 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No lymph node metastases, <italic>n</italic>&#160;=&#160;44</td>
###xml 1324 1325 1324 1325 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1318 1334 1318 1334 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">26.0, <italic>p</italic>&#160;&lt;&#160;0.0001</td>
###xml 1203 1334 1203 1334 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Lymph node metastases at total thyroidectomy, total <italic>n</italic>&#160;=&#160;8</td><td align="left">Lymph nodes present, <italic>n</italic>&#160;=&#160;8</td><td align="left">No lymph node metastases, <italic>n</italic>&#160;=&#160;44</td><td align="left">26.0, <italic>p</italic>&#160;&lt;&#160;0.0001</td></tr>
###xml 1334 1383 1334 1383 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">Surgery at an appropriate age based on risk level</td>
###xml 1387 1388 1387 1388 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1383 1393 1383 1393 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No, <italic>n</italic>&#160;=&#160;16</td>
###xml 1397 1398 1397 1398 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1393 1403 1393 1403 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No, <italic>n</italic>&#160;=&#160;31</td>
###xml 1408 1409 1408 1409 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1403 1417 1403 1417 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">9.3, <italic>p</italic>&#160;=&#160;0.002</td>
###xml 1334 1417 1334 1417 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" rowspan="2">Surgery at an appropriate age based on risk level</td><td align="left">No, <italic>n</italic>&#160;=&#160;16</td><td align="left">No, <italic>n</italic>&#160;=&#160;31</td><td align="left" rowspan="2">9.3, <italic>p</italic>&#160;=&#160;0.002</td></tr>
###xml 1422 1423 1422 1423 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1417 1427 1417 1427 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Yes, <italic>n</italic>&#160;=&#160;0</td>
###xml 1432 1433 1432 1433 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1427 1438 1427 1438 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Yes, <italic>n</italic>&#160;=&#160;13</td>
###xml 1417 1438 1417 1438 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Yes, <italic>n</italic>&#160;=&#160;0</td><td align="left">Yes, <italic>n</italic>&#160;=&#160;13</td></tr>
###xml 1457 1460 1457 1460 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 1475 1478 1475 1478 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 1438 1482 1438 1482 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">Surgery in the pre-<italic>RET</italic> era or in the <italic>RET</italic> era</td>
###xml 1486 1489 1486 1489 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 1491 1492 1491 1492 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1482 1496 1482 1496 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Pre-<italic>RET</italic>, <italic>n</italic>&#160;=&#160;7</td>
###xml 1500 1503 1500 1503 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 1505 1506 1505 1506 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1496 1511 1496 1511 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Pre-<italic>RET</italic>, <italic>n</italic>&#160;=&#160;11</td>
###xml 1511 1536 1511 1536 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No significant difference</td>
###xml 1438 1536 1438 1536 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" rowspan="2">Surgery in the pre-<italic>RET</italic> era or in the <italic>RET</italic> era</td><td align="left">Pre-<italic>RET</italic>, <italic>n</italic>&#160;=&#160;7</td><td align="left">Pre-<italic>RET</italic>, <italic>n</italic>&#160;=&#160;11</td><td align="left">No significant difference</td></tr>
###xml 1536 1539 1536 1539 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 1545 1546 1545 1546 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1536 1550 1536 1550 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>RET</italic> era, <italic>n</italic>&#160;=&#160;9</td>
###xml 1550 1553 1550 1553 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 1559 1560 1559 1560 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1550 1565 1550 1565 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>RET</italic> era, <italic>n</italic>&#160;=&#160;33</td>
###xml 1565 1566 1565 1566 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1565 1573 1565 1573 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>p</italic>&#160;=&#160;0.14</td>
###xml 1536 1573 1536 1573 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>RET</italic> era, <italic>n</italic>&#160;=&#160;9</td><td align="left"><italic>RET</italic> era, <italic>n</italic>&#160;=&#160;33</td><td align="left"><italic>p</italic>&#160;=&#160;0.14</td></tr>
###xml 1573 1573 1573 1573 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1573 1573 1573 1573 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1573 1573 1573 1573 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1573 1574 1573 1574 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1596 1597 1596 1597 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">U</italic>
###xml 1604 1605 1604 1605 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1573 1627 1573 1627 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>t</italic> test or Mann&#8211;Whitney <italic>U</italic> test, <italic>p</italic> value, and odds ratio</td>
###xml 1573 1627 1573 1627 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"/><td align="left"/><td align="left"/><td align="left"><italic>t</italic> test or Mann&#8211;Whitney <italic>U</italic> test, <italic>p</italic> value, and odds ratio</td></tr>
###xml 1646 1647 1646 1647 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 1627 1663 1627 1663 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Mean age at surgery<sup>c</sup> (years) (range)</td>
###xml 1663 1682 1663 1682 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">12.1 (range&#160;=&#160;1&#8211;19)</td>
###xml 1682 1700 1682 1700 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">8.6 (range&#160;=&#160;1&#8211;19)</td>
###xml 1700 1701 1700 1701 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1700 1727 1700 1727 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>p</italic>&#160;=&#160;0.002, 95% CI&#160;=&#160;1.2&#8211;5.7</td>
###xml 1627 1727 1627 1727 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Mean age at surgery<sup>c</sup> (years) (range)</td><td align="left">12.1 (range&#160;=&#160;1&#8211;19)</td><td align="left">8.6 (range&#160;=&#160;1&#8211;19)</td><td align="left"><italic>p</italic>&#160;=&#160;0.002, 95% CI&#160;=&#160;1.2&#8211;5.7</td></tr>
###xml 1757 1758 1755 1756 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 1727 1758 1727 1756 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Mean follow-up (years) (&#177;SD)<sup>d</sup></td>
###xml 1758 1771 1756 1767 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">12.3 (&#177;7.1)</td>
###xml 1771 1783 1767 1777 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">7.4 (&#177;4.7)</td>
###xml 1783 1784 1777 1778 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1783 1810 1777 1804 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>p</italic>&#160;=&#160;0.004, 95% CI&#160;=&#160;1.6&#8211;8.0</td>
###xml 1727 1810 1727 1804 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Mean follow-up (years) (&#177;SD)<sup>d</sup></td><td align="left">12.3 (&#177;7.1)</td><td align="left">7.4 (&#177;4.7)</td><td align="left"><italic>p</italic>&#160;=&#160;0.004, 95% CI&#160;=&#160;1.6&#8211;8.0</td></tr>
###xml 925 1810 925 1804 <tbody xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">Preoperative calcitonin levels elevated</td><td align="left"><italic>N</italic>&#160;=&#160;13 (81%)</td><td align="left"><italic>N</italic>&#160;=&#160;20 (46%)</td><td align="left">6.5, <italic>p</italic>&#160;=&#160;0.011</td></tr><tr><td align="left" rowspan="6">Codon<sup>a</sup></td><td align="left">634, <italic>n</italic>&#160;=&#160;11</td><td align="left">634, <italic>n</italic>&#160;=&#160;35</td><td align="left" rowspan="6">10.7, <italic>p</italic>&#160;=&#160;0.03</td></tr><tr><td align="left">918, <italic>n</italic>&#160;=&#160;4</td><td align="left">618, <italic>n</italic>&#160;=&#160;3</td></tr><tr><td align="left">Unknown, <italic>n</italic>&#160;=&#160;1</td><td align="left">620, <italic>n</italic>&#160;=&#160;1</td></tr><tr><td align="left"/><td align="left">611, <italic>n</italic>&#160;=&#160;3</td></tr><tr><td align="left"/><td align="left">918, <italic>n</italic>&#160;=&#160;1</td></tr><tr><td align="left"/><td align="left">Unknown, <italic>n</italic>&#160;=&#160;1</td></tr><tr><td align="left">Risk level<sup>b</sup></td><td align="left"/><td align="left"/><td align="left" rowspan="5">7.1, <italic>p</italic>&#160;=&#160;0.007</td></tr><tr><td align="left">&#160;1</td><td align="left"><italic>n</italic>&#160;=&#160;0</td><td align="left"><italic>n</italic>&#160;=&#160;0</td></tr><tr><td align="left">&#160;2</td><td align="left"><italic>n</italic>&#160;=&#160;11</td><td align="left"><italic>n</italic>&#160;=&#160;42</td></tr><tr><td align="left">&#160;3</td><td align="left"><italic>n</italic>&#160;=&#160;4</td><td align="left"><italic>n</italic>&#160;=&#160;1</td></tr><tr><td align="left">&#160;Unknown</td><td align="left"><italic>n</italic>&#160;=&#160;1</td><td align="left"><italic>n</italic>&#160;=&#160;1</td></tr><tr><td align="left">Lymph node metastases at total thyroidectomy, total <italic>n</italic>&#160;=&#160;8</td><td align="left">Lymph nodes present, <italic>n</italic>&#160;=&#160;8</td><td align="left">No lymph node metastases, <italic>n</italic>&#160;=&#160;44</td><td align="left">26.0, <italic>p</italic>&#160;&lt;&#160;0.0001</td></tr><tr><td align="left" rowspan="2">Surgery at an appropriate age based on risk level</td><td align="left">No, <italic>n</italic>&#160;=&#160;16</td><td align="left">No, <italic>n</italic>&#160;=&#160;31</td><td align="left" rowspan="2">9.3, <italic>p</italic>&#160;=&#160;0.002</td></tr><tr><td align="left">Yes, <italic>n</italic>&#160;=&#160;0</td><td align="left">Yes, <italic>n</italic>&#160;=&#160;13</td></tr><tr><td align="left" rowspan="2">Surgery in the pre-<italic>RET</italic> era or in the <italic>RET</italic> era</td><td align="left">Pre-<italic>RET</italic>, <italic>n</italic>&#160;=&#160;7</td><td align="left">Pre-<italic>RET</italic>, <italic>n</italic>&#160;=&#160;11</td><td align="left">No significant difference</td></tr><tr><td align="left"><italic>RET</italic> era, <italic>n</italic>&#160;=&#160;9</td><td align="left"><italic>RET</italic> era, <italic>n</italic>&#160;=&#160;33</td><td align="left"><italic>p</italic>&#160;=&#160;0.14</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"><italic>t</italic> test or Mann&#8211;Whitney <italic>U</italic> test, <italic>p</italic> value, and odds ratio</td></tr><tr><td align="left">Mean age at surgery<sup>c</sup> (years) (range)</td><td align="left">12.1 (range&#160;=&#160;1&#8211;19)</td><td align="left">8.6 (range&#160;=&#160;1&#8211;19)</td><td align="left"><italic>p</italic>&#160;=&#160;0.002, 95% CI&#160;=&#160;1.2&#8211;5.7</td></tr><tr><td align="left">Mean follow-up (years) (&#177;SD)<sup>d</sup></td><td align="left">12.3 (&#177;7.1)</td><td align="left">7.4 (&#177;4.7)</td><td align="left"><italic>p</italic>&#160;=&#160;0.004, 95% CI&#160;=&#160;1.6&#8211;8.0</td></tr></tbody>
###xml 785 1810 785 1804 <table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left">Factor</th><th align="left">Residual/recurrent disease (<italic>n</italic>&#160;=&#160;16, 27%) (<italic>n</italic>, %)</th><th align="left">No evidence of residual/recurrent disease (<italic>n</italic>&#160;=&#160;44, 73%) (<italic>n</italic>, %)</th><th align="left">Likelihood-ratio, <italic>p</italic> value</th></tr></thead><tbody><tr><td align="left">Preoperative calcitonin levels elevated</td><td align="left"><italic>N</italic>&#160;=&#160;13 (81%)</td><td align="left"><italic>N</italic>&#160;=&#160;20 (46%)</td><td align="left">6.5, <italic>p</italic>&#160;=&#160;0.011</td></tr><tr><td align="left" rowspan="6">Codon<sup>a</sup></td><td align="left">634, <italic>n</italic>&#160;=&#160;11</td><td align="left">634, <italic>n</italic>&#160;=&#160;35</td><td align="left" rowspan="6">10.7, <italic>p</italic>&#160;=&#160;0.03</td></tr><tr><td align="left">918, <italic>n</italic>&#160;=&#160;4</td><td align="left">618, <italic>n</italic>&#160;=&#160;3</td></tr><tr><td align="left">Unknown, <italic>n</italic>&#160;=&#160;1</td><td align="left">620, <italic>n</italic>&#160;=&#160;1</td></tr><tr><td align="left"/><td align="left">611, <italic>n</italic>&#160;=&#160;3</td></tr><tr><td align="left"/><td align="left">918, <italic>n</italic>&#160;=&#160;1</td></tr><tr><td align="left"/><td align="left">Unknown, <italic>n</italic>&#160;=&#160;1</td></tr><tr><td align="left">Risk level<sup>b</sup></td><td align="left"/><td align="left"/><td align="left" rowspan="5">7.1, <italic>p</italic>&#160;=&#160;0.007</td></tr><tr><td align="left">&#160;1</td><td align="left"><italic>n</italic>&#160;=&#160;0</td><td align="left"><italic>n</italic>&#160;=&#160;0</td></tr><tr><td align="left">&#160;2</td><td align="left"><italic>n</italic>&#160;=&#160;11</td><td align="left"><italic>n</italic>&#160;=&#160;42</td></tr><tr><td align="left">&#160;3</td><td align="left"><italic>n</italic>&#160;=&#160;4</td><td align="left"><italic>n</italic>&#160;=&#160;1</td></tr><tr><td align="left">&#160;Unknown</td><td align="left"><italic>n</italic>&#160;=&#160;1</td><td align="left"><italic>n</italic>&#160;=&#160;1</td></tr><tr><td align="left">Lymph node metastases at total thyroidectomy, total <italic>n</italic>&#160;=&#160;8</td><td align="left">Lymph nodes present, <italic>n</italic>&#160;=&#160;8</td><td align="left">No lymph node metastases, <italic>n</italic>&#160;=&#160;44</td><td align="left">26.0, <italic>p</italic>&#160;&lt;&#160;0.0001</td></tr><tr><td align="left" rowspan="2">Surgery at an appropriate age based on risk level</td><td align="left">No, <italic>n</italic>&#160;=&#160;16</td><td align="left">No, <italic>n</italic>&#160;=&#160;31</td><td align="left" rowspan="2">9.3, <italic>p</italic>&#160;=&#160;0.002</td></tr><tr><td align="left">Yes, <italic>n</italic>&#160;=&#160;0</td><td align="left">Yes, <italic>n</italic>&#160;=&#160;13</td></tr><tr><td align="left" rowspan="2">Surgery in the pre-<italic>RET</italic> era or in the <italic>RET</italic> era</td><td align="left">Pre-<italic>RET</italic>, <italic>n</italic>&#160;=&#160;7</td><td align="left">Pre-<italic>RET</italic>, <italic>n</italic>&#160;=&#160;11</td><td align="left">No significant difference</td></tr><tr><td align="left"><italic>RET</italic> era, <italic>n</italic>&#160;=&#160;9</td><td align="left"><italic>RET</italic> era, <italic>n</italic>&#160;=&#160;33</td><td align="left"><italic>p</italic>&#160;=&#160;0.14</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"><italic>t</italic> test or Mann&#8211;Whitney <italic>U</italic> test, <italic>p</italic> value, and odds ratio</td></tr><tr><td align="left">Mean age at surgery<sup>c</sup> (years) (range)</td><td align="left">12.1 (range&#160;=&#160;1&#8211;19)</td><td align="left">8.6 (range&#160;=&#160;1&#8211;19)</td><td align="left"><italic>p</italic>&#160;=&#160;0.002, 95% CI&#160;=&#160;1.2&#8211;5.7</td></tr><tr><td align="left">Mean follow-up (years) (&#177;SD)<sup>d</sup></td><td align="left">12.3 (&#177;7.1)</td><td align="left">7.4 (&#177;4.7)</td><td align="left"><italic>p</italic>&#160;=&#160;0.004, 95% CI&#160;=&#160;1.6&#8211;8.0</td></tr></tbody></table>
###xml 1810 1812 1804 1806 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
###xml 1810 1832 1804 1826 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="42"><italic>CI</italic> confidence interval</p>
###xml 1832 1833 1826 1827 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1832 2064 1826 2058 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="43"><sup>a</sup>We calculated the percentage of patients who had MTC who were cured per codon. Seventy-six percent of patients with codon 634, 100% of patients with a 618, 620, and 611 mutation, and only 20% of those with a 918 mutation were cured</p>
###xml 2064 2065 2058 2059 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 2064 2177 2058 2171 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="44"><sup>b</sup>When we analyzed this for risk level, 79% of the patients with risk level 2 and 20% with risk level 3 were cured</p>
###xml 2177 2178 2171 2172 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 2177 2246 2171 2240 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="45"><sup>c</sup>Single factor also significantly associated in multivariate analysis</p>
###xml 2246 2247 2240 2241 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 2373 2376 2367 2370 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 2246 2400 2240 2394 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="46"><sup>d</sup>The duration of follow-up, however, was not statistically different between both groups after excluding patients from the pre-<italic>RET</italic> era (8.2 vs. 6.2&#160;years)</p>
###xml 1810 2400 1804 2394 <table-wrap-foot xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="42"><italic>CI</italic> confidence interval</p><p textid="43"><sup>a</sup>We calculated the percentage of patients who had MTC who were cured per codon. Seventy-six percent of patients with codon 634, 100% of patients with a 618, 620, and 611 mutation, and only 20% of those with a 918 mutation were cured</p><p textid="44"><sup>b</sup>When we analyzed this for risk level, 79% of the patients with risk level 2 and 20% with risk level 3 were cured</p><p textid="45"><sup>c</sup>Single factor also significantly associated in multivariate analysis</p><p textid="46"><sup>d</sup>The duration of follow-up, however, was not statistically different between both groups after excluding patients from the pre-<italic>RET</italic> era (8.2 vs. 6.2&#160;years)</p></table-wrap-foot>
###xml 683 2400 683 2394 <table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab3"><label>Table&#160;3</label><caption><p textid="41">Factors associated with residual or recurrent disease in patients with MTC; univariate analysis</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Factor</th><th align="left">Residual/recurrent disease (<italic>n</italic>&#160;=&#160;16, 27%) (<italic>n</italic>, %)</th><th align="left">No evidence of residual/recurrent disease (<italic>n</italic>&#160;=&#160;44, 73%) (<italic>n</italic>, %)</th><th align="left">Likelihood-ratio, <italic>p</italic> value</th></tr></thead><tbody><tr><td align="left">Preoperative calcitonin levels elevated</td><td align="left"><italic>N</italic>&#160;=&#160;13 (81%)</td><td align="left"><italic>N</italic>&#160;=&#160;20 (46%)</td><td align="left">6.5, <italic>p</italic>&#160;=&#160;0.011</td></tr><tr><td align="left" rowspan="6">Codon<sup>a</sup></td><td align="left">634, <italic>n</italic>&#160;=&#160;11</td><td align="left">634, <italic>n</italic>&#160;=&#160;35</td><td align="left" rowspan="6">10.7, <italic>p</italic>&#160;=&#160;0.03</td></tr><tr><td align="left">918, <italic>n</italic>&#160;=&#160;4</td><td align="left">618, <italic>n</italic>&#160;=&#160;3</td></tr><tr><td align="left">Unknown, <italic>n</italic>&#160;=&#160;1</td><td align="left">620, <italic>n</italic>&#160;=&#160;1</td></tr><tr><td align="left"/><td align="left">611, <italic>n</italic>&#160;=&#160;3</td></tr><tr><td align="left"/><td align="left">918, <italic>n</italic>&#160;=&#160;1</td></tr><tr><td align="left"/><td align="left">Unknown, <italic>n</italic>&#160;=&#160;1</td></tr><tr><td align="left">Risk level<sup>b</sup></td><td align="left"/><td align="left"/><td align="left" rowspan="5">7.1, <italic>p</italic>&#160;=&#160;0.007</td></tr><tr><td align="left">&#160;1</td><td align="left"><italic>n</italic>&#160;=&#160;0</td><td align="left"><italic>n</italic>&#160;=&#160;0</td></tr><tr><td align="left">&#160;2</td><td align="left"><italic>n</italic>&#160;=&#160;11</td><td align="left"><italic>n</italic>&#160;=&#160;42</td></tr><tr><td align="left">&#160;3</td><td align="left"><italic>n</italic>&#160;=&#160;4</td><td align="left"><italic>n</italic>&#160;=&#160;1</td></tr><tr><td align="left">&#160;Unknown</td><td align="left"><italic>n</italic>&#160;=&#160;1</td><td align="left"><italic>n</italic>&#160;=&#160;1</td></tr><tr><td align="left">Lymph node metastases at total thyroidectomy, total <italic>n</italic>&#160;=&#160;8</td><td align="left">Lymph nodes present, <italic>n</italic>&#160;=&#160;8</td><td align="left">No lymph node metastases, <italic>n</italic>&#160;=&#160;44</td><td align="left">26.0, <italic>p</italic>&#160;&lt;&#160;0.0001</td></tr><tr><td align="left" rowspan="2">Surgery at an appropriate age based on risk level</td><td align="left">No, <italic>n</italic>&#160;=&#160;16</td><td align="left">No, <italic>n</italic>&#160;=&#160;31</td><td align="left" rowspan="2">9.3, <italic>p</italic>&#160;=&#160;0.002</td></tr><tr><td align="left">Yes, <italic>n</italic>&#160;=&#160;0</td><td align="left">Yes, <italic>n</italic>&#160;=&#160;13</td></tr><tr><td align="left" rowspan="2">Surgery in the pre-<italic>RET</italic> era or in the <italic>RET</italic> era</td><td align="left">Pre-<italic>RET</italic>, <italic>n</italic>&#160;=&#160;7</td><td align="left">Pre-<italic>RET</italic>, <italic>n</italic>&#160;=&#160;11</td><td align="left">No significant difference</td></tr><tr><td align="left"><italic>RET</italic> era, <italic>n</italic>&#160;=&#160;9</td><td align="left"><italic>RET</italic> era, <italic>n</italic>&#160;=&#160;33</td><td align="left"><italic>p</italic>&#160;=&#160;0.14</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"><italic>t</italic> test or Mann&#8211;Whitney <italic>U</italic> test, <italic>p</italic> value, and odds ratio</td></tr><tr><td align="left">Mean age at surgery<sup>c</sup> (years) (range)</td><td align="left">12.1 (range&#160;=&#160;1&#8211;19)</td><td align="left">8.6 (range&#160;=&#160;1&#8211;19)</td><td align="left"><italic>p</italic>&#160;=&#160;0.002, 95% CI&#160;=&#160;1.2&#8211;5.7</td></tr><tr><td align="left">Mean follow-up (years) (&#177;SD)<sup>d</sup></td><td align="left">12.3 (&#177;7.1)</td><td align="left">7.4 (&#177;4.7)</td><td align="left"><italic>p</italic>&#160;=&#160;0.004, 95% CI&#160;=&#160;1.6&#8211;8.0</td></tr></tbody></table><table-wrap-foot><p textid="42"><italic>CI</italic> confidence interval</p><p textid="43"><sup>a</sup>We calculated the percentage of patients who had MTC who were cured per codon. Seventy-six percent of patients with codon 634, 100% of patients with a 618, 620, and 611 mutation, and only 20% of those with a 918 mutation were cured</p><p textid="44"><sup>b</sup>When we analyzed this for risk level, 79% of the patients with risk level 2 and 20% with risk level 3 were cured</p><p textid="45"><sup>c</sup>Single factor also significantly associated in multivariate analysis</p><p textid="46"><sup>d</sup>The duration of follow-up, however, was not statistically different between both groups after excluding patients from the pre-<italic>RET</italic> era (8.2 vs. 6.2&#160;years)</p></table-wrap-foot></table-wrap>
###xml 539 547 <span type="species:ncbi:9606">patients</span>
###xml 747 755 <span type="species:ncbi:9606">patients</span>
###xml 1865 1873 <span type="species:ncbi:9606">patients</span>
###xml 1935 1943 <span type="species:ncbi:9606">patients</span>
###xml 1968 1976 <span type="species:ncbi:9606">patients</span>
###xml 2114 2122 <span type="species:ncbi:9606">patients</span>
###xml 2351 2359 <span type="species:ncbi:9606">patients</span>
Univariate analysis showed that a higher age at surgery, no age-appropriate prophylactic surgery, affected codon and risk level, preoperative calcitonin level, and lymph node metastasis at operation were associated significantly with persistent or recurrent disease (Table 3). No association was seen with gender and different variants of codon 634 mutations. In multivariate analysis, only surgery at an older age was significantly associated with persistent or recurrent disease. In both the pre-RET era and the RET era, the majority of patients were not operated on at an age-appropriate age, but the percentage was significantly higher in the pre-RET era (96 vs. 69%, p = 0.004).Table 3Factors associated with residual or recurrent disease in patients with MTC; univariate analysisFactorResidual/recurrent disease (n = 16, 27%) (n, %)No evidence of residual/recurrent disease (n = 44, 73%) (n, %)Likelihood-ratio, p valuePreoperative calcitonin levels elevatedN = 13 (81%)N = 20 (46%)6.5, p = 0.011Codona634, n = 11634, n = 3510.7, p = 0.03918, n = 4618, n = 3Unknown, n = 1620, n = 1611, n = 3918, n = 1Unknown, n = 1Risk levelb7.1, p = 0.007 1n = 0n = 0 2n = 11n = 42 3n = 4n = 1 Unknownn = 1n = 1Lymph node metastases at total thyroidectomy, total n = 8Lymph nodes present, n = 8No lymph node metastases, n = 4426.0, p < 0.0001Surgery at an appropriate age based on risk levelNo, n = 16No, n = 319.3, p = 0.002Yes, n = 0Yes, n = 13Surgery in the pre-RET era or in the RET eraPre-RET, n = 7Pre-RET, n = 11No significant differenceRET era, n = 9RET era, n = 33p = 0.14t test or Mann-Whitney U test, p value, and odds ratioMean age at surgeryc (years) (range)12.1 (range = 1-19)8.6 (range = 1-19)p = 0.002, 95% CI = 1.2-5.7Mean follow-up (years) (+/-SD)d12.3 (+/-7.1)7.4 (+/-4.7)p = 0.004, 95% CI = 1.6-8.0CI confidence intervalaWe calculated the percentage of patients who had MTC who were cured per codon. Seventy-six percent of patients with codon 634, 100% of patients with a 618, 620, and 611 mutation, and only 20% of those with a 918 mutation were curedbWhen we analyzed this for risk level, 79% of the patients with risk level 2 and 20% with risk level 3 were curedcSingle factor also significantly associated in multivariate analysisdThe duration of follow-up, however, was not statistically different between both groups after excluding patients from the pre-RET era (8.2 vs. 6.2 years)
###end p 40
###begin p 41
###xml 57 65 <span type="species:ncbi:9606">patients</span>
Factors associated with residual or recurrent disease in patients with MTC; univariate analysis
###end p 41
###begin p 42
###xml 0 2 0 2 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">CI</italic>
CI confidence interval
###end p 42
###begin p 43
###xml 0 1 0 1 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 33 41 <span type="species:ncbi:9606">patients</span>
###xml 103 111 <span type="species:ncbi:9606">patients</span>
###xml 136 144 <span type="species:ncbi:9606">patients</span>
aWe calculated the percentage of patients who had MTC who were cured per codon. Seventy-six percent of patients with codon 634, 100% of patients with a 618, 620, and 611 mutation, and only 20% of those with a 918 mutation were cured
###end p 43
###begin p 44
###xml 0 1 0 1 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 50 58 <span type="species:ncbi:9606">patients</span>
bWhen we analyzed this for risk level, 79% of the patients with risk level 2 and 20% with risk level 3 were cured
###end p 44
###begin p 45
###xml 0 1 0 1 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
cSingle factor also significantly associated in multivariate analysis
###end p 45
###begin p 46
###xml 0 1 0 1 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 127 130 127 130 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 105 113 <span type="species:ncbi:9606">patients</span>
dThe duration of follow-up, however, was not statistically different between both groups after excluding patients from the pre-RET era (8.2 vs. 6.2 years)
###end p 46
###begin p 47
###xml 978 981 978 981 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 998 1001 998 1001 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 1013 1014 1013 1014 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 1290 1291 1290 1291 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab4" ref-type="table">4</xref>
###xml 1292 1299 1292 1299 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;4</label>
###xml 1371 1374 1371 1374 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 1299 1398 1299 1398 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="48">Earliest presentation of medullary thyroid carcinoma in patients with a <italic>RET</italic> proto-oncogene mutation</p>
###xml 1299 1398 1299 1398 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="48">Earliest presentation of medullary thyroid carcinoma in patients with a <italic>RET</italic> proto-oncogene mutation</p></caption>
###xml 1409 1412 1409 1412 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 1398 1436 1398 1436 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">Codon with <italic>RET</italic> mutation and risk level</th>
###xml 1436 1479 1436 1479 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">Earliest age at presentation of MTC (years)</th>
###xml 1479 1534 1479 1534 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">Earliest age of LN metastases in current series (years)</th>
###xml 1534 1603 1534 1603 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">Earliest age at presentation of MTC with LN metastases (years) (Ref.)</th>
###xml 1398 1603 1398 1603 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="2">Codon with <italic>RET</italic> mutation and risk level</th><th align="left" colspan="2">Earliest age at presentation of MTC (years)</th><th align="left" rowspan="2">Earliest age of LN metastases in current series (years)</th><th align="left" rowspan="2">Earliest age at presentation of MTC with LN metastases (years) (Ref.)</th></tr>
###xml 1603 1617 1603 1617 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Current series</th>
###xml 1617 1623 1617 1623 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(Ref.)</th>
###xml 1603 1623 1603 1623 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Current series</th><th align="left">(Ref.)</th></tr>
###xml 1398 1623 1398 1623 <thead xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="2">Codon with <italic>RET</italic> mutation and risk level</th><th align="left" colspan="2">Earliest age at presentation of MTC (years)</th><th align="left" rowspan="2">Earliest age of LN metastases in current series (years)</th><th align="left" rowspan="2">Earliest age at presentation of MTC with LN metastases (years) (Ref.)</th></tr><tr><th align="left">Current series</th><th align="left">(Ref.)</th></tr></thead>
###xml 1623 1631 1623 1631 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">918 RL 3</td>
###xml 1631 1635 1631 1635 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.13</td>
###xml 1641 1642 1641 1642 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 1635 1643 1635 1643 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.75 [<xref ref-type="bibr" rid="CR9">9</xref>]</td>
###xml 1643 1645 1643 1645 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11</td>
###xml 1650 1652 1650 1652 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 1645 1653 1645 1653 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2.7 [<xref ref-type="bibr" rid="CR15">15</xref>]</td>
###xml 1623 1653 1623 1653 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">918 RL 3</td><td align="left">1.13</td><td align="left">0.75 [<xref ref-type="bibr" rid="CR9">9</xref>]</td><td char="." align="char">11</td><td align="left">2.7 [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr>
###xml 1653 1661 1653 1661 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">634 RL 2</td>
###xml 1661 1665 1661 1665 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.25</td>
###xml 1670 1672 1670 1672 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 1665 1673 1665 1673 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.1 [<xref ref-type="bibr" rid="CR15">15</xref>]</td>
###xml 1673 1674 1673 1674 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7</td>
###xml 1677 1679 1677 1679 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 1674 1680 1674 1680 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5 [<xref ref-type="bibr" rid="CR15">15</xref>]</td>
###xml 1653 1680 1653 1680 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">634 RL 2</td><td align="left">1.25</td><td align="left">1.1 [<xref ref-type="bibr" rid="CR15">15</xref>]</td><td char="." align="char">7</td><td align="left">5 [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr>
###xml 1680 1688 1680 1688 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">611 RL 2</td>
###xml 1688 1689 1688 1689 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">6</td>
###xml 1692 1693 1692 1693 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 1689 1694 1689 1694 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3 [<xref ref-type="bibr" rid="CR9">9</xref>]</td>
###xml 1694 1695 1694 1695 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8211;</td>
###xml 1699 1701 1699 1701 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 1695 1702 1695 1702 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">28 [<xref ref-type="bibr" rid="CR21">21</xref>]</td>
###xml 1680 1702 1680 1702 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">611 RL 2</td><td align="left">6</td><td align="left">3 [<xref ref-type="bibr" rid="CR9">9</xref>]</td><td char="." align="char">&#8211;</td><td align="left">28 [<xref ref-type="bibr" rid="CR21">21</xref>]</td></tr>
###xml 1702 1710 1702 1710 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">620 RL 2</td>
###xml 1710 1711 1710 1711 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">6</td>
###xml 1714 1716 1714 1716 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 1711 1717 1711 1717 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5 [<xref ref-type="bibr" rid="CR10">10</xref>]</td>
###xml 1717 1718 1717 1718 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8211;</td>
###xml 1722 1724 1722 1724 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 1718 1725 1718 1725 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">22 [<xref ref-type="bibr" rid="CR15">15</xref>]</td>
###xml 1702 1725 1702 1725 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">620 RL 2</td><td align="left">6</td><td align="left">5 [<xref ref-type="bibr" rid="CR10">10</xref>]</td><td char="." align="char">&#8211;</td><td align="left">22 [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr>
###xml 1725 1733 1725 1733 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">618 RL 2</td>
###xml 1733 1735 1733 1735 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">12</td>
###xml 1738 1739 1738 1739 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 1735 1740 1735 1740 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">7 [<xref ref-type="bibr" rid="CR9">9</xref>]</td>
###xml 1740 1741 1740 1741 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8211;</td>
###xml 1745 1747 1745 1747 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 1749 1751 1749 1751 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 1753 1755 1753 1755 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 1741 1756 1741 1756 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">11 [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]</td>
###xml 1725 1756 1725 1756 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">618 RL 2</td><td align="left">12</td><td align="left">7 [<xref ref-type="bibr" rid="CR9">9</xref>]</td><td char="." align="char">&#8211;</td><td align="left">11 [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]</td></tr>
###xml 1756 1764 1756 1764 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">804 RL 1</td>
###xml 1764 1765 1764 1765 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1768 1770 1768 1770 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 1765 1771 1765 1771 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">6 [<xref ref-type="bibr" rid="CR24">24</xref>]</td>
###xml 1771 1772 1771 1772 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8211;</td>
###xml 1775 1777 1775 1777 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 1772 1778 1772 1778 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">6 [<xref ref-type="bibr" rid="CR24">24</xref>]</td>
###xml 1756 1778 1756 1778 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">804 RL 1</td><td align="left">&#8211;</td><td align="left">6 [<xref ref-type="bibr" rid="CR24">24</xref>]</td><td char="." align="char">&#8211;</td><td align="left">6 [<xref ref-type="bibr" rid="CR24">24</xref>]</td></tr>
###xml 1623 1778 1623 1778 <tbody xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">918 RL 3</td><td align="left">1.13</td><td align="left">0.75 [<xref ref-type="bibr" rid="CR9">9</xref>]</td><td char="." align="char">11</td><td align="left">2.7 [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">634 RL 2</td><td align="left">1.25</td><td align="left">1.1 [<xref ref-type="bibr" rid="CR15">15</xref>]</td><td char="." align="char">7</td><td align="left">5 [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">611 RL 2</td><td align="left">6</td><td align="left">3 [<xref ref-type="bibr" rid="CR9">9</xref>]</td><td char="." align="char">&#8211;</td><td align="left">28 [<xref ref-type="bibr" rid="CR21">21</xref>]</td></tr><tr><td align="left">620 RL 2</td><td align="left">6</td><td align="left">5 [<xref ref-type="bibr" rid="CR10">10</xref>]</td><td char="." align="char">&#8211;</td><td align="left">22 [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">618 RL 2</td><td align="left">12</td><td align="left">7 [<xref ref-type="bibr" rid="CR9">9</xref>]</td><td char="." align="char">&#8211;</td><td align="left">11 [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]</td></tr><tr><td align="left">804 RL 1</td><td align="left">&#8211;</td><td align="left">6 [<xref ref-type="bibr" rid="CR24">24</xref>]</td><td char="." align="char">&#8211;</td><td align="left">6 [<xref ref-type="bibr" rid="CR24">24</xref>]</td></tr></tbody>
###xml 1398 1778 1398 1778 <table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Codon with <italic>RET</italic> mutation and risk level</th><th align="left" colspan="2">Earliest age at presentation of MTC (years)</th><th align="left" rowspan="2">Earliest age of LN metastases in current series (years)</th><th align="left" rowspan="2">Earliest age at presentation of MTC with LN metastases (years) (Ref.)</th></tr><tr><th align="left">Current series</th><th align="left">(Ref.)</th></tr></thead><tbody><tr><td align="left">918 RL 3</td><td align="left">1.13</td><td align="left">0.75 [<xref ref-type="bibr" rid="CR9">9</xref>]</td><td char="." align="char">11</td><td align="left">2.7 [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">634 RL 2</td><td align="left">1.25</td><td align="left">1.1 [<xref ref-type="bibr" rid="CR15">15</xref>]</td><td char="." align="char">7</td><td align="left">5 [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">611 RL 2</td><td align="left">6</td><td align="left">3 [<xref ref-type="bibr" rid="CR9">9</xref>]</td><td char="." align="char">&#8211;</td><td align="left">28 [<xref ref-type="bibr" rid="CR21">21</xref>]</td></tr><tr><td align="left">620 RL 2</td><td align="left">6</td><td align="left">5 [<xref ref-type="bibr" rid="CR10">10</xref>]</td><td char="." align="char">&#8211;</td><td align="left">22 [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">618 RL 2</td><td align="left">12</td><td align="left">7 [<xref ref-type="bibr" rid="CR9">9</xref>]</td><td char="." align="char">&#8211;</td><td align="left">11 [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]</td></tr><tr><td align="left">804 RL 1</td><td align="left">&#8211;</td><td align="left">6 [<xref ref-type="bibr" rid="CR24">24</xref>]</td><td char="." align="char">&#8211;</td><td align="left">6 [<xref ref-type="bibr" rid="CR24">24</xref>]</td></tr></tbody></table>
###xml 1778 1781 1778 1781 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MTC</italic>
###xml 1811 1813 1811 1813 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">LN</italic>
###xml 1854 1856 1854 1856 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RL</italic>
###xml 1986 1988 1986 1988 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 1990 1992 1990 1992 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 1778 1993 1778 1993 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="49"><italic>MTC</italic> medullary thyroid carcinoma, <italic>LN</italic> lymph node metastasis; -, not observed, <italic>RL</italic> risk level of MTC based on the 1999 consensus statement from the Seventh International Workshop on Multiple Endocrine Neoplasia [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]</p>
###xml 1778 1993 1778 1993 <table-wrap-foot xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="49"><italic>MTC</italic> medullary thyroid carcinoma, <italic>LN</italic> lymph node metastasis; -, not observed, <italic>RL</italic> risk level of MTC based on the 1999 consensus statement from the Seventh International Workshop on Multiple Endocrine Neoplasia [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]</p></table-wrap-foot>
###xml 1292 1993 1292 1993 <table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab4"><label>Table&#160;4</label><caption><p textid="48">Earliest presentation of medullary thyroid carcinoma in patients with a <italic>RET</italic> proto-oncogene mutation</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Codon with <italic>RET</italic> mutation and risk level</th><th align="left" colspan="2">Earliest age at presentation of MTC (years)</th><th align="left" rowspan="2">Earliest age of LN metastases in current series (years)</th><th align="left" rowspan="2">Earliest age at presentation of MTC with LN metastases (years) (Ref.)</th></tr><tr><th align="left">Current series</th><th align="left">(Ref.)</th></tr></thead><tbody><tr><td align="left">918 RL 3</td><td align="left">1.13</td><td align="left">0.75 [<xref ref-type="bibr" rid="CR9">9</xref>]</td><td char="." align="char">11</td><td align="left">2.7 [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">634 RL 2</td><td align="left">1.25</td><td align="left">1.1 [<xref ref-type="bibr" rid="CR15">15</xref>]</td><td char="." align="char">7</td><td align="left">5 [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">611 RL 2</td><td align="left">6</td><td align="left">3 [<xref ref-type="bibr" rid="CR9">9</xref>]</td><td char="." align="char">&#8211;</td><td align="left">28 [<xref ref-type="bibr" rid="CR21">21</xref>]</td></tr><tr><td align="left">620 RL 2</td><td align="left">6</td><td align="left">5 [<xref ref-type="bibr" rid="CR10">10</xref>]</td><td char="." align="char">&#8211;</td><td align="left">22 [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">618 RL 2</td><td align="left">12</td><td align="left">7 [<xref ref-type="bibr" rid="CR9">9</xref>]</td><td char="." align="char">&#8211;</td><td align="left">11 [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]</td></tr><tr><td align="left">804 RL 1</td><td align="left">&#8211;</td><td align="left">6 [<xref ref-type="bibr" rid="CR24">24</xref>]</td><td char="." align="char">&#8211;</td><td align="left">6 [<xref ref-type="bibr" rid="CR24">24</xref>]</td></tr></tbody></table><table-wrap-foot><p textid="49"><italic>MTC</italic> medullary thyroid carcinoma, <italic>LN</italic> lymph node metastasis; -, not observed, <italic>RL</italic> risk level of MTC based on the 1999 consensus statement from the Seventh International Workshop on Multiple Endocrine Neoplasia [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]</p></table-wrap-foot></table-wrap>
###xml 31 39 <span type="species:ncbi:9606">patients</span>
###xml 90 98 <span type="species:ncbi:9606">patients</span>
###xml 190 198 <span type="species:ncbi:9606">patients</span>
###xml 213 221 <span type="species:ncbi:9606">patients</span>
###xml 429 437 <span type="species:ncbi:9606">patients</span>
###xml 536 544 <span type="species:ncbi:9606">patients</span>
###xml 568 576 <span type="species:ncbi:9606">patients</span>
###xml 720 727 <span type="species:ncbi:9606">patient</span>
###xml 830 838 <span type="species:ncbi:9606">patients</span>
###xml 946 954 <span type="species:ncbi:9606">patients</span>
###xml 1029 1037 <span type="species:ncbi:9606">patients</span>
###xml 1355 1363 <span type="species:ncbi:9606">patients</span>
On histological examination 61 patients had already developed MTC (66%), whereas 30 (32%) patients displayed C-cell hyperplasia. Histological examination showed no abnormalities in only two patients. One of these patients had a Cys634Gly mutation and was operated on at the age of 1 year. The other had a Cys620Ser mutation and was 5 years of age at the time of surgery. There was no significant difference in median age between patients with C-cell hyperplasia and MTC (8.0 vs. 9.7 years). Lymph node metastases were observed in eight patients and were found only in patients with the Met918Thr mutation associated with MEN 2B syndrome and the Cys634Arg mutation, which is associated with MEN 2A syndrome. The youngest patient with lymph node metastases was 7 years old and had a Cys634Arg mutation. The median age at surgery of patients with histological lymph node metastases was 13 years (IQR = 10-14). We found more lymph node metastases in patients operated on in the pre-RET era than in the RET era (Table 2). None of the patients who had lymph node metastases had a normal preoperative calcitonin level and none had calcitonin levels lower than 40 pg/ml. An overview of the earliest age at which MTC was demonstrated per codon in our series compared to literature is given in Table 4.Table 4Earliest presentation of medullary thyroid carcinoma in patients with a RET proto-oncogene mutationCodon with RET mutation and risk levelEarliest age at presentation of MTC (years)Earliest age of LN metastases in current series (years)Earliest age at presentation of MTC with LN metastases (years) (Ref.)Current series(Ref.)918 RL 31.130.75 [9]112.7 [15]634 RL 21.251.1 [15]75 [15]611 RL 263 [9]-28 [21]620 RL 265 [10]-22 [15]618 RL 2127 [9]-11 [10, 22, 23]804 RL 1-6 [24]-6 [24]MTC medullary thyroid carcinoma, LN lymph node metastasis; -, not observed, RL risk level of MTC based on the 1999 consensus statement from the Seventh International Workshop on Multiple Endocrine Neoplasia [11, 15]
###end p 47
###begin p 48
###xml 72 75 72 75 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
Earliest presentation of medullary thyroid carcinoma in patients with a RET proto-oncogene mutation
###end p 48
###begin p 49
###xml 0 3 0 3 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MTC</italic>
###xml 33 35 33 35 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">LN</italic>
###xml 76 78 76 78 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RL</italic>
###xml 208 210 208 210 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 212 214 212 214 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
MTC medullary thyroid carcinoma, LN lymph node metastasis; -, not observed, RL risk level of MTC based on the 1999 consensus statement from the Seventh International Workshop on Multiple Endocrine Neoplasia [11, 15]
###end p 49
###begin title 50
Follow-up
###end title 50
###begin p 51
###xml 705 706 705 706 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab3" ref-type="table">3</xref>
###xml 94 102 <span type="species:ncbi:9606">patients</span>
###xml 233 241 <span type="species:ncbi:9606">patients</span>
###xml 327 335 <span type="species:ncbi:9606">patients</span>
###xml 494 502 <span type="species:ncbi:9606">patients</span>
###xml 593 601 <span type="species:ncbi:9606">patients</span>
###xml 713 721 <span type="species:ncbi:9606">patients</span>
###xml 815 823 <span type="species:ncbi:9606">patients</span>
###xml 923 930 <span type="species:ncbi:9606">patient</span>
The median follow-up period was 7 years (IQR = 3-11). At the time of the last visit, 75 (81%) patients were disease-free according to the postoperative calcitonin levels. The duration of follow-up was significantly different between patients who had persistent or recurrent disease and those who were cured. Thirteen of the 16 patients with persistent or recurrent disease at follow-up had elevated basal calcitonin or pentagastrin-stimulated calcitonin levels preoperatively. None of these 16 patients had been operated on at an appropriate age recommended by the guidelines. Three of the 27 patients who had MTC and normal preoperative calcitonin levels developed persistent or recurrent disease (Table 3). All patients with lymph node metastases at operation developed persistent or recurrent disease. All eight patients underwent a central neck dissection and five of them a lateral neck dissection as well. One MEN 2B patient died at the age of 18 (i.e., 6 years postoperatively) because of metastatic disease. No differences in presentation could be found between the different codon 634 mutations in terms of age at surgery and recurrent disease.
###end p 51
###begin p 52
###xml 56 59 56 59 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 178 179 178 179 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 248 249 248 249 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 333 334 333 334 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 370 371 370 371 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 537 540 537 540 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 15 23 <span type="species:ncbi:9606">patients</span>
###xml 65 73 <span type="species:ncbi:9606">patients</span>
###xml 266 274 <span type="species:ncbi:9606">patients</span>
###xml 515 523 <span type="species:ncbi:9606">patients</span>
If we excluded patients who were operated on in the pre-RET era, patients who had persistent or recurrent disease were still older than those who were cured (12.3 vs. 7.9 years, p = 0.01) and were less frequently operated on at an appropriate age (p = 0.034). These patients more often had an elevated preoperative calcitonin level (p = 0.04) and lymph node metastasis (p = 0.001) compared to those who were cured. The duration of follow-up, however, was not statistically different for both groups after excluding patients from the pre-RET era (8.2 vs. 6.2 years).
###end p 52
###begin title 53
Discussion
###end title 53
###begin p 54
###xml 241 244 241 244 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 161 169 <span type="species:ncbi:9606">patients</span>
###xml 304 312 <span type="species:ncbi:9606">patients</span>
###xml 340 348 <span type="species:ncbi:9606">patients</span>
###xml 421 429 <span type="species:ncbi:9606">patients</span>
Due to the well-organized infrastructure of the relatively small country of the Netherlands, we were able to establish a unique nationwide overview of all Dutch patients with hereditary MTC who underwent a total thyroidectomy based on their RET proto-oncogene mutation since 1980. In the Netherlands all patients with MTC, especially young patients, are operated on in a university hospital. We included in our study all patients who underwent surgery in those hospitals and it is therefore unlikely that our results are biased because of selection of the population.
###end p 54
###begin p 55
###xml 705 706 705 706 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 708 709 708 709 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 711 712 711 712 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 109 117 <span type="species:ncbi:9606">patients</span>
###xml 743 751 <span type="species:ncbi:9606">patients</span>
###xml 971 979 <span type="species:ncbi:9606">patients</span>
###xml 1140 1148 <span type="species:ncbi:9606">patients</span>
###xml 1306 1314 <span type="species:ncbi:9606">patients</span>
We evaluated potential prognostic factors responsible for the outcome of prophylactic thyroidectomy in MEN 2 patients. The presence of lymph node metastasis, elevated preoperative calcitonin levels, codon/risk level, no age-appropriate prophylactic surgery, and a higher age at surgery were associated with persistent/recurrent disease in univariate analysis. Higher age at surgery was the only independent prognostic variable for persistent or recurrent disease in multivariate analysis. This could be an indication that having the operation at an earlier age might lead to a better outcome, thus preventing recurrent disease. It appears that progression from C-cell hyperplasia into MTC is age-related [4, 5, 9]. Twenty-three percent of the patients who were operated on at a higher age than is currently recommended by the guidelines developed recurrent disease. These data, once again underline the importance of early, prophylactic surgery. However, the majority of patients who had C-cell hyperplasia were not operated on at the recommended age either. Based on the latter observation the argument could also be reversed because many patients are cured despite the fact that they are operated on at an older age than is recommended. We do, however, want to keep in mind that almost one-fourth of the patients with MTC operated on at an older age developed persistent or recurrent disease.
###end p 55
###begin p 56
###xml 19 27 <span type="species:ncbi:9606">patients</span>
###xml 126 134 <span type="species:ncbi:9606">patients</span>
###xml 186 193 <span type="species:ncbi:9606">patient</span>
In our series, all patients with nodal metastases had persistent or recurrent disease. Lymph node metastases appeared only in patients who were operated on at a relatively high age. One patient with persistent disease (elevated calcitonin levels) was only 1 year old (codon 918 mutation). Therefore, we believe that prophylactic thyroidectomy should not be delayed until after the age recommended in literature.
###end p 56
###begin p 57
###xml 315 316 315 316 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 318 320 318 320 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 58 66 <span type="species:ncbi:9606">Patients</span>
###xml 211 219 <span type="species:ncbi:9606">patients</span>
Three risk levels have been identified in the literature. Patients in the highest-risk level (level 3: codons 918, 883, and 922) tend to have an aggressive presentation of MTC. In our cohort, as expected, these patients presented with MTC at an early age. Therefore, they are in need of a more aggressive approach [9, 15].
###end p 57
###begin p 58
###xml 50 58 <span type="species:ncbi:9606">children</span>
###xml 139 144 <span type="species:ncbi:9606">child</span>
###xml 317 325 <span type="species:ncbi:9606">patients</span>
Persistent and recurrent disease occurred only in children with mutations in codons 918 and 634. Furthermore, we found MTC in a 1-year-old child with a codon 634 mutation. Since no differences in biological behavior in follow-up were observed between the different codon 634 mutations in our series, we feel that all patients with a codon 634 mutation should be managed in the same manner.
###end p 58
###begin p 59
###xml 232 234 232 234 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 392 395 392 395 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 539 542 539 542 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 555 558 555 558 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
Having surgery at a younger age is believed to be associated with a higher complication rate but we found no evidence of this in our study. The complication rate is more or less comparable with other series, even in the very young [16]. In addition, in our study, performing a central neck dissection was not associated with a higher complication rate. More complications occurred in the pre-RET era group. Although the numbers are too small to draw any firm conclusions, we think this difference between the complication rates of the pre-RET era and the RET era may was a result of the improvements in operative technique. Since endocrine surgeons are more experienced in thyroid surgery than pediatric surgeons, it is common practice in the Netherlands to perform surgery together to decrease the complication risk.
###end p 59
###begin p 60
###xml 183 185 183 185 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 327 328 327 328 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 330 332 330 332 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 699 700 699 700 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 13 20 <span type="species:ncbi:9606">patient</span>
###xml 150 157 <span type="species:ncbi:9606">patient</span>
###xml 270 278 <span type="species:ncbi:9606">patients</span>
###xml 472 480 <span type="species:ncbi:9606">patients</span>
###xml 553 561 <span type="species:ncbi:9606">patients</span>
###xml 607 615 <span type="species:ncbi:9606">patients</span>
The youngest patient in our series with lymph node metastasis was 7 years old and carried a codon 634 mutation. Another report describes a 5-year-old patient with a nodal metastasis [17]. This is in contrast with two other large series in which lymph node metastases in patients younger than 11 and 14 years were not observed [9, 10]. A central neck dissection is controversial. We do not think it is necessary to perform a routine prophylactic central neck dissection on patients younger than 5 years or if preoperative calcitonin levels are normal in patients who do not have MEN 2B syndrome. None of our patients with lymph node metastases had a normal preoperative elevated calcitonin. Machens [4] has suggested that a central neck dissection be performed if preoperative calcitonin levels are elevated, regardless of age.
###end p 60
###begin p 61
###xml 313 315 313 315 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 316 318 316 318 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 358 360 358 360 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 550 552 550 552 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 52 59 <span type="species:ncbi:9606">patient</span>
###xml 170 177 <span type="species:ncbi:9606">patient</span>
###xml 477 485 <span type="species:ncbi:9606">patients</span>
###xml 543 548 <span type="species:ncbi:9606">child</span>
###xml 674 681 <span type="species:ncbi:9606">patient</span>
As mentioned above, one MEN 2B (codon 918 mutation) patient with MTC and persistent disease after surgery was only 1 year old. In previous reports, MTC was reported in a patient with this mutation within the first 6 months of life. Furthermore, persistent disease has been reported within the first year of life [18-20]. Therefore, the consensus guidelines [11] recommend a total thyroidectomy together with a central lymph node dissection before the age of 6 months in MEN 2B patients. Lymph node metastases have been found in a 2.7-year-old child [18]. The 1 year old (codon 918) who had persistent disease in our series did not undergo a central neck dissection. The one patient who died in our series had MEN 2B syndrome (Met918Tyr mutation) and had been operated on when 12 years old.
###end p 61
###begin p 62
###xml 229 230 229 230 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 232 234 232 234 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 621 623 621 623 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 0 8 <span type="species:ncbi:9606">Children</span>
###xml 137 145 <span type="species:ncbi:9606">patients</span>
###xml 585 593 <span type="species:ncbi:9606">patients</span>
Children with a risk level 2 (codon 634, 611, 618, or 620 mutation) have a high risk of developing MTC. Some reports have suggested that patients with a 634 mutation may be regarded as a separate group with a higher risk of MTC [9, 15]. When we regarded codon 634 as a separate group, no recurrences of MTC were found in risk group 2 (codons 611, 618, and 620). However, the knowledge that elevated preoperative calcitonin levels and/or suspicion of lymph node involvement means an increased risk of recurrent disease supports the advice of the consensus meeting to perform surgery on patients younger than the age of 5 [11].
###end p 62
###begin p 63
###xml 599 601 599 601 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 30 38 <span type="species:ncbi:9606">children</span>
###xml 325 332 <span type="species:ncbi:9606">patient</span>
###xml 465 473 <span type="species:ncbi:9606">patients</span>
###xml 613 620 <span type="species:ncbi:9606">patient</span>
It is generally believed that children with a relatively low risk (risk level 1) of developing MTC because of a germline mutation at codon 609, 768, 790, 791, 804, or 891 should undergo a total thyroidectomy as well. The biological behavior of MTC in this group is less aggressive, which is confirmed in our cohort. The only patient in this group did not have MTC. Controversy remains regarding the age at which surgery should be performed. While some believe that patients in this category should be operated on before the age of 5, others advocate surgery in this risk group before the age of 10 [11]. However, patient numbers in our series were too small to draw any conclusions.
###end p 63
###begin p 64
###xml 138 141 138 141 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 281 284 281 284 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 318 321 318 321 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 376 379 376 379 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 511 514 511 514 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 249 257 <span type="species:ncbi:9606">patients</span>
###xml 354 362 <span type="species:ncbi:9606">patients</span>
###xml 489 497 <span type="species:ncbi:9606">patients</span>
Limitations of this study are its retrospective nature and its associated disadvantages such as missing data from laboratory studies, the RET mutation in two cases, and indications for central neck dissection. Furthermore, as expected we found that patients operated on in the pre-RET era were older than those in the RET era. A larger proportion of the patients from the pre-RET era were not operated on at an appropriate age and had more lymph node metastases. However, when we excluded patients from the pre-RET era, the same factors were still associated with persistent disease.
###end p 64
###begin p 65
###xml 123 126 123 126 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RET</italic>
###xml 102 110 <span type="species:ncbi:9606">patients</span>
###xml 176 184 <span type="species:ncbi:9606">patients</span>
###xml 331 339 <span type="species:ncbi:9606">patients</span>
###xml 418 426 <span type="species:ncbi:9606">patients</span>
Prophylactic thyroidectomy at a younger age is associated with less recurrence or metastasized MTC in patients harboring a RET mutation. Recurrent disease was observed only in patients with the 634 and 918 codon mutations who did not undergo total thyroidectomy at an appropriate age. Therefore, it seems justifiable to operate on patients in the very-high-risk group at an early age, as is currently recommended. All patients with codon 634 mutations should be treated equally.
###end p 65
###begin p 66
###xml 223 230 <span type="species:ncbi:9606">persons</span>
###xml 325 333 <span type="species:ncbi:9606">Children</span>
This work was supported by the Dutch Cancer Society and the Michael van Vloten Fund of the Dutch Surgical Association. On behalf of the endocrine and pediatric surgery working groups, we acknowledge and thank the following persons and participating centers for their involvement in this nationwide study: D. C. Aronson: Emma Children's Hospital AMC, Academic Medical Center/Free University Medical Center, Amsterdam; J. Th. M. Plukker, Th. Links, A. H. Brouwers, R. Rassouli, T. Wiggers, R. Hofstra, and J. W. de Groot: University Medical Center Groningen; J. F. Hamming, B. A. Bonsing, and J. Kievit: Leiden University Medical Center; N. D. Bouvy: Academic Hospital Maastricht; M. Wijnen: Radboud University Medical Center Nijmegen; T. L. v.d. Hoonaard and N. M. A. Bax: Erasmus Medical Center Rotterdam; J. M. J. Schreinemakers, M. R. Vriens, I. H.M. Borel Rinkes, G. D. Valk, R. B. van der Luijt, J. K. Ploos van Amstel, and D. C. v.d. Zee: University Medical Center Utrecht.
###end p 66
###begin p 67
###xml 0 11 0 11 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 67
###begin title 68
References
###end title 68
###begin article-title 69
Hyperparathyroidism in multiple endocrine neoplasia syndrome
###end article-title 69
###begin article-title 70
Multiple endocrine neoplasia type 2 Clinical features and screening
###end article-title 70
###begin article-title 71
Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 carriers of RET germline mutations
###end article-title 71
###begin article-title 72
Advances in the management of hereditary medullary thyroid cancer
###end article-title 72
###begin article-title 73
C-cell hyperplasia preceding medullary thyroid carcinoma
###end article-title 73
###begin article-title 74
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC
###end article-title 74
###begin article-title 75
Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A
###end article-title 75
###begin article-title 76
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
###end article-title 76
###begin article-title 77
Early malignant progression of hereditary medullary thyroid cancer
###end article-title 77
###begin article-title 78
Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A
###end article-title 78
###begin article-title 79
Guidelines for diagnosis and therapy of MEN type 1 and type 2
###end article-title 79
###begin article-title 80
###xml 30 38 <span type="species:ncbi:9606">children</span>
Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature
###end article-title 80
###begin article-title 81
The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience
###end article-title 81
###begin article-title 82
Treatment of medullary thyroid carcinoma: an update
###end article-title 82
###begin article-title 83
Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinoma
###end article-title 83
###begin article-title 84
###xml 33 41 <span type="species:ncbi:9606">children</span>
Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience
###end article-title 84
###begin article-title 85
Early presentation of metastatic medullary carcinoma in multiple endocrine neoplasia, type IIA: implications for therapy
###end article-title 85
###begin article-title 86
Multiple endocrine syndrome type IIb in early childhood
###end article-title 86
###begin article-title 87
###xml 31 39 <span type="species:ncbi:9606">children</span>
Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B
###end article-title 87
###begin article-title 88
Medullary carcinoma of the thyroid before age 2 years
###end article-title 88
###begin article-title 89
Presentation of a kindred with familial medullary thyroid carcinoma and Cys611Phe mutation of the RET proto-oncogene demonstrating low grade malignancy
###end article-title 89
###begin article-title 90
Phenotypic expression of a family with multiple endocrine neoplasia type 2A due to a RET mutation at codon 618
###end article-title 90
###begin article-title 91
Description of the first two seemingly unrelated Greek Cypriot families with a common C618R RET proto-oncogene mutation
###end article-title 91
###begin article-title 92
Update on the MEN 2A c804 RET mutation: is prophylactic thyroidectomy indicated?
###end article-title 92

